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Abstract 
Heterocyclic compounds have undisputed significance in disciplines that stretch across 
chemistry and biology. The ever-growing utility of heterocyclic chemistry spans the 
development of therapeutic agents, catalysis and ligand design, to the preparation of chemical 
probes utilized in biological investigations. The chemistry described in this thesis focuses on 
reaction development for the generation of extensively functionalized polyoxygenated 
heterocycles and the incorporation of these synthetic tools in the arena of natural product 
synthesis.  
Chapter One introduces the dogma of discovering new pharmaceutical leads by 
acknowledging long-appreciated traditional medicinal knowledge in the context of 
ethnomycology. The biosynthetic analyses of several key bioactive fungal metabolites are 
subsequently discussed, underpinning the string of synthetic campaigns presented in this 
thesis.  
Chapter Two describes the evolution of a new synthetic method that strategically exploits 
the intrinsic reactivity of o-benzoquinones within the confines of dibenzofuran synthesis. 
The nascent idea was brought to maturity with the development of an unconventional 
approach whereby the target dibenzo[b,d]furan scaffold was directly constructed through the 
union of simple phenols/naphthols and o-benzoquinones through a Michael-oxidation-oxa-
Michael sequence. The scope of this transformation was evaluated with a broad range of 
phenolic substrates and a tactical insertion of this methodology into a total synthesis 
endeavor led to a concise synthesis of two dibenzofuran natural products. 
Chapter Three details a nine-step synthesis of boletopsin 11, a polyoxygenated p-terphenyl 
dibenzofuran fungal metabolite. Our synthetic approach employs a one-pot oxidation-oxa-
Michael sequence ensued by a palladium-catalyzed directed ortho-C(sp2)-H arylation reaction 
to forge efficiently the entirety of the carbon skeleton. Efforts directed at optimizing the 
latter reaction revealed a tandem ortho-C(sp2)-H arylation event—an unprecedented mode of 
reactivity which superseded the scope of the original methodology report. 
Chapter Four outlines the first total synthesis of suillusin. The molecular framework was 
constructed in one step using a multicatalytic Michael-benzoin condensation cascade 
followed by a Rubottom-Swern oxidation strategy to yield the requisite oxidation state of the 
skeletal framework. The successful completion of the synthesis enabled the investigation of 
the enantiopurity of the natural isolate and its unexplored biosynthetic origin.  
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Introduction 
Synthetic Chemistry Driven by Ethnomycology  
Throughout the centuries, fungi have been an integral part of human civilization, tradition 
and culture.1 The study of ethnomycology probes the intimate and multifaceted relationship 
between mushrooms and society, including the usage of fungi in culinary and medicinal 
contexts—both of which are crucial elements that significantly impact the quality of life. 
Located in the southwestern Pacific, Papua New Guinea has a heavily forested, tropical 
climate and a large proportion of the population living traditional lifestyles, which enables 
this part of the world to be rich in ethnomycology.2 In particular, the humid environment of 
Papua New Guinea has provided a fertile setting for enhancing biodiversity and speciation 
of fungi, many of which have been incorporated into traditional Papua New Guinean 
medicine.1 Remedies which have been passed down for centuries are often characterized by 
their inherently low toxicity as medicinal treatments.3 Thus, embracing traditional medicinal 
knowledge can offer a significant advantage in developing new therapeutic leads over 
standard drug discovery practices. 
The overarching goal of our research program was to chemically dissect, interpret and 
conserve the medicinal ethnomycology that has progressed in the indigenous Papua New 
Guinean communities. In practice, this mission has served as a basis for our desire to develop 
new synthetic methodology to access novel polyoxygenated heterocyclic scaffolds. The 
majority of synthetic targets presented throughout this thesis have been isolated as the 
bioactive components of mushrooms that have been utilized in traditional medicinal 
applications.  
As part of our ongoing investigation to correlate the chemical and biological properties of 
fungi used in traditional medicine, we became interested in a mushroom identified as a 
Boletopsis sp. This fungus has been utilized by people of the Kiovi tribe of Lufa District in the 
Eastern Highlands Province as food and medicine to treat gastrointestinal discomfort.4 In 
2013, our laboratory reported the discovery of boletopsins 11 (1) and 12 (2) together with 
other known related natural products from this Boletopsis sp. guided by antibiotic assays of 
the mushroom extracts (Figure 1).2  
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Figure 1. Boletopsins 11 (1), 12 (2), 13 (3) and 14 (4) 
From the same fungus, two polybrominated boletopsin analogues (boletopsins 13 (3) and 14 
(4)) were subsequently isolated and identified in 2015.5 The biological activity, in addition to 
the inherently low toxicity of the boletopsins, rendered them appealing targets for further 
biological evaluation. However, an imminent need for new synthetic blueprints precluded 
rigorous biological analysis. Chapter Two addresses this requirement and details the 
underpinning rationale and synthetic methodology development aimed at the rapid assembly 
of the key carbon framework. Chapter Three describes our synthetic approach to the 
boletopsins through application of the strategies founded in Chapter Two together with 
methodological insights into a novel mode of directed C-H functionalization.  
Biosynthesis of p-Terphenyl Fungal Natural Products 
Organisms that contain the biological machinery to produce p-terphenyl compounds are 
unique to fungi including those found in lichens.6 These molecules constitute a significant 
portion of the family of fungal pigments and also present a vast array of bioactivity ranging 
from antioxidant to anti-inflammatory properties.7 Chemical research towards p-terphenyl 
fungal natural products emerged in the 1870s6 with the isolation of polyporic acid (5),8 
atromentin (6)9 and thelephoric acid (7)10 as part of investigations aimed at identifying new 
fungal pigments and dyes (Figure 2). Our discovery of boletopsin 11 (1) in 20132 was 
accompanied with the isolation of cycloleucomelone (8),11 a p-terphenylquinone which was 
first discovered in 1987 by Steglich and co-workers.12 Vialinin B (9)13, a structurally related 
molecule isolated from a Chinese edible fungus Thelephora vialis was found to be a potent 
inhibitor of tumor necrosis factor (TNF)-α production. More recent progress on the isolation, 
synthetic and biological investigations of p-terphenyls and structurally related natural 
products have been extensively reviewed in several literature reports.6,14-16  
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Figure 2. Representative examples of p-terphenyl derived fungal natural products 
Fungal p-terphenyl natural products arise from the shikimate pathway through the 
dimerization of two arylpyruvic acid units.7 As depicted in Scheme 1, enzymatic 
phosphorylation and addition of phosphoenolpyruvate (PEP) to shikimic acid (10) followed 
by a sequence of elimination reactions generates chorismic acid (11).17 Subsequently, 
chorismic acid (11) is converted to prephenic acid (12) through a Claisen rearrangement 
catalyzed by chorismate mutase.18 Decarboxylative aromatization of prephenic acid (12) 
affords phenylpyruvic acid (13)—the characteristic C6C3 arylpropanone unit found in many 
shikimate-derived natural products.  
Scheme 1. Accessing Phenylpyruvic Acids through the Shikimic Acid Pathway 
  
The 4-hydroxy derivative 14 can be formed in the presence of a dehydrogenase which 
oxidizes the 4-OH of prephenic acid (12) to the corresponding ketone oxidation state.17 Thus, 
the 4-hydroxy functionality is retained after decarboxylative aromatization to give 4-
hydroxyphenylpyruvic acid (14), which serves as the key building block in the biogenesis of 
atromentin (6) and other highly oxygenated polyporic acid analogues. Intrinsically, this route 
also reveals a pathway to aromatic amino acids including phenylalanine, tyrosine and 
tryptophan. Interconversion of the amino acids and their analogous pyruvic acids is 
considered to be mediated through pyridoxal phosphate (PLP)-catalyzed transamination 
processes.19 
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The final step of the biosynthetic pathway involves an enzyme-mediated condensation of 
two arylpyruvic acid units to yield the tetraketone 15 which preferentially exists as the enol 
tautomer 16, revealing the central 2,5-dihydroxy-p-quinone core of the p-terphenyl carbon 
skeleton (Scheme 2).20  
Scheme 2. p-Terphenyl Framework Formed through Dimerization of Arylpyruvic Acids 
 
Isotope labelling studies using [3-13C]phenylalanine and [3’-13C]tyrosine with Tapinella 
atrotomentosa have confirmed the exclusive incorporation of [3’-13C]tyrosine into the isolated 
atromentin (6), indicating the hydroxylation of the terminal aromatic substituents occurs 
prior to the dimerization step.16 This conclusion was further supported by another 
experiment in which L-phenyl[U-14C]alanine was administered to Hapalopilus rutilans, resulting 
in the production of 14C-enriched polyporic acid.12 These p-terphenylquinone frameworks 
have also been isolated in the form of substituted hydroquinone analogues, such as vialinin 
B (9) and the boletopsins (1-4). Our nine-step synthesis of boletopsin 11 (1), which was 
enabled by reaction discovery and strategy development will be further discussed in Chapter 
Two and Chapter Three. 
Oxidative Ring Contraction of the p-Terphenylquinone Core 
p-Terphenylquinones can also serve as key intermediates for other structural classes of fungal 
metabolites bearing highly oxygenated carbon scaffolds. The remaining sections of Chapter 
One will focus on the biogenesis of polyoxygenated 2,5-diarylcyclopentenone fungal 
metabolites and their congeners which are formed through oxidative modification of the p-
terphenylquinone precursor.21 Some of these diarylcyclopentenoid fungal natural products 
have been found in fungal pigments and are responsible for the “blueing” or brown staining 
phenomena observed upon bruising of the fruiting bodies, owing to their proclivity towards 
rapid oxidation when exposed to air (Scheme 3).12  
Exhaustive chemical and biosynthetic investigations of these oxygen-rich 
diarylcyclopentenones have been detailed in a comprehensive review of fungal pigments 
compiled by Gill and Steglich in 1987.12 The study focused on the occurrence of several 
oxygen-rich diarylcyclopentenones, including gyrocyanin (17),22 gyroporin (18),22 chamonixin 
(19),22 involutin (20)23 and anhydroinvolutin (21),12 which have been isolated from various 
species of Boletales (Scheme 3). The blue coloration of the damaged fruiting bodies of 
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Gyroporus cyanescens was found to be caused by the oxidation of gyrocyanin (17) to the intensely 
colored o-quinone methide anion 22, which could be reverted to gyrocyanin (17) when treated 
with ascorbic acid.22 Treatment of 22 with dilute mineral acid led to the conjugate addition 
of water to the quinone methide, resulting in the formation of gyroporin (18)—another 
natural product found in several species of fungi.12 
Scheme 3. Some Examples of Fungal Diarylcyclopentenone Natural Products 
 
The most compelling biosynthetic pathway towards this structural motif is proposed to arise 
through the oxidative rearrangement of atromentin (6), which has been mimicked in a 
laboratory setting in Steglich and Zipfel’s biomimetic synthesis of gyroporin (18) (Scheme 
4).24  
Scheme 4. Steglich and Zipfel’s Biomimetic Synthesis of Gyroporin (18) 
 
Mechanistically, oxidation of atromentin (6) with K3[Fe(CN)6] is believed to generate 
quinone methide 23 which then undergoes a benzilic acid rearrangement to afford 
carboxylate 24. Decarboxylation and oxidation of carboxylate 24 yields the intensely colored 
anion 22, which is then treated with phosphoric acid to give gyroporin (18) in 19% yield.  
In 2012, Tomoda and co-workers reported the discovery of racemic fungal natural products 
(±)-tylopilusins A (25) and B (26) isolated from Tylopilus eximius (Figure 3).25  
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Figure 3. (±)-Tylopilusins A (25) and B (26) and intermediary carboxylate 24 
The remarkable structural similarity between the tylopilusins and the carboxylate 
intermediate 24 postulated by Steglich and Zipfel immediately led us to speculate that the 
tylopilusins are also produced through a common metabolic pathway as gyroporin (18). 
Additionally, the racemic nature of (±)-tylopilusins A (25) and B (26) raised the possibility 
that the oxidative ring contraction is mediated through an abiotic process rather than through 
enzymatic intervention.  
The biosynthetic proposal was further examined by Hoffmeister and co-workers in 201526 
through a biochemical approach to elucidate the origin of diarylcyclopentenone compounds 
produced by the fungus Paxillus involutus. The multidisciplinary analysis exploited genetic and 
transcriptomic techniques as well as isotope labelling studies to validate atromentin (6) as the 
most plausible metabolic precursor. Alternative pathways that had been suggested by Gill 
and Steglich12 intersected with atromentic acid (27) as a biosynthetic intermediate (Scheme 5 
pathway A), or proceeded via a dimerization of 4-hydroxyphenylpyruvic acid derivative 
(Scheme 5 pathway B).  
Scheme 5. Other Suggested Biosynthetic Pathways of Diarylcyclopentenoids 
 
Collectively, the biosynthetic principles highlighted in each of these aforementioned studies 
all stand as firm evidence of the hypothesis that diarylcyclopentenone fungal metabolites are 
formed through predisposed oxidative rearrangement of the p-terphenylquinone precursor. 
This concept will reemerge in Chapter Four. 
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Suillusin – a Unique Benzofuran Fungal Natural Product  
Our venture into the domain of p-terphenyl and p-terphenylquinone-derived compounds 
ultimately led us to encounter suillusin (28), a polyoxygenated heterocyclic natural product 
which was first isolated from Suillus granulatus by Yoo and co-workers in 2001 (Figure 4).27 
Suillusin features an intriguing 1H-cyclopenta[b]benzofuran core which is heavily decorated 
with oxygen-rich functionalities. Interestingly, structural searches initiated by this oxygenated 
framework yielded meager results, revealing a substantial gap in the existing natural product 
literature. The small handful of compounds which share the same core structure as suillusin 
were mainly comprised of complex polyphenols, namely the oolongtheanins (29a-29d)28,29 
and oenotherin T2 (30)
30 as shown in Figure 4.  
 
Figure 4. Examples of other natural product frameworks that map onto the core scaffold of suillusin 
From a synthetic standpoint, suillusin’s atypical structural motif was identified as an excellent 
proving ground for the development of efficient strategies for broad translation into 
heterocyclic chemistry. In addition, as shown in Scheme 6, the molecular framework of 
suillusin presents noticeable similarity to those of (±)-tylopilusins A (25) and B (26), 
prompting conjecture that the origin of suillusin (28) is akin to the biogenesis of the 
tylopilusins.  
Scheme 6. Structural Similarity between the Tylopilusins (25-26) and Suillusin (28) 
 
Chapter Four details our 10-step total synthesis of suillusin, which fills this structural void 
in the synthetic literature, and sheds light on the biosynthesis of the natural product.  
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Introduction 
Reactivity of o-Benzoquinones 
o-Benzoquinones remain relatively underrepresented in the realm of synthetic chemistry, 
despite their ease of preparation from the oxidative dearomatization of catechols and 
phenolic precursors using mild reaction conditions.31-33 The potential of o-benzoquinones to 
participate in myriad reaction pathways affords these chemical entities a capricious reputation 
that often foreshadows complications in predicting reaction outcome and optimizing 
reaction conditions (Figure 5).34 Nevertheless, with controlled chemoselectivity, o-
benzoquinones have the capacity to act as powerful six-carbon synthons in accessing 
structurally diverse carbon frameworks.  
 
Figure 5. Various modes of reactivity of o-benzoquinones 
The cyclic conjugated nature of o-benzoquinone allows for nucleophilic attack to occur via 
1,2-addition, 1,4-addition and 1,6-addition (Figure 5A). o-Benzoquinones can also react with 
low-valent metals through a two-electron oxidation process to generate metal catecholate 
complexes (Figure 5B).35,36 Furthermore, the configurationally locked cyclic s-cis diene as well 
as the hetero diene comprised of the two adjacent carbonyl groups can be utilized in Diels-
Alder and hetero Diels-Alder chemistry (Figure 5C).31,37,38  
The ‘masked’ counterpart of o-benzoquinone, where one of the carbonyl functionalities is 
protected with an acetal group (e.g. compound 31), has comparable reactivity to the parent 
o-benzoquinone but superior stability. o-Benzoquinone monoketals have already been 
successfully incorporated into an array of elegant total syntheses, many of which have been 
extensively reviewed.39-41 The remaining part of this introduction will focus on studies that 
explored the capacity of o-benzoquinones as oxidants as well as their use in conjugate 
addition chemistry. Both concepts are subjects of discussion for the development of the 
Michael-oxidation-oxa-Michael reaction cascade which will be detailed in the ensuing 
sections of Chapter Two. 
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Applications of o-Benzoquinones in Conjugate Addition Chemistries  
In 2009, Pettus and co-workers reported a study that probed the reactivity of 3-benzyloxy-o-
benzoquinone (32) with a variety of organometallic reagents.42 A collection of nucleophiles 
were tested, ranging from Grignard reagents, organotin and organozinc compounds and 
boronic esters that produced various 1,2 or 1,4-addition products (Scheme 7). The majority 
of the Grignard additions led to the formation of the 1,2-adduct, but interestingly, formation 
of the 1,4-adduct 33 was observed with allylmagnesium bromide when o-benzoquinone 32 
was precomplexed with BF3·Et2O. 
Scheme 7. Chemoselective 1,2 and 1,4-Additions to 3-Benzyloxy-o-Benzoquinone (32) 
  
Similar results were obtained with allyltributyl tin and when an allylboronic acid pinacol ester 
was utilized, the 1,4-addition proceeded in the absence of BF3·Et2O. Mechanistically, rather 
than a straightforward Michael addition, the authors suggest the nucleophilic allyl group 
initially adds in a 1,2-fashion through a six-membered transition state (Scheme 8). The quinol 
34 then undergoes a [1,2]-shift. Subsequent [3,3]-sigmatropic rearrangement followed by 
keto-enol tautomerization would then afford the formal “1,4-addition” product.  
Scheme 8. Proposed Mechanism for the Formal 1,4-Addition to 3-Benzyloxy-o-Benzoquinone (32) 
 
An assortment of other nucleophilic reagents was also evaluated, as shown in Scheme 9. Low 
temperatures were required throughout the study due to the proclivity of o-benzoquinones 
to undergo homodimerization.  
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Scheme 9. Representative Examples of Other Nucleophilic Reagents 
 
Most candidates proved unreactive or led to the net reduction of the starting material to form 
3-benzyloxycatechol, highlighting the difficulty of controlling the reactivity of o-
benzoquinone. Two successful examples were present among the study, including the 1,4-
addition of enolate 35 to o-quinone 32, which delivered catechol 36 and the 1,6-addition of 
thiophenol to afford aryl thioether 37 in moderate yields. These positive outcomes highlight 
the potential of employing a conjugate addition strategy in the functionalization of o-
benzoquinone—a subject of discussion in the latter part of Chapter Two. 
In 2016, Lumb and co-workers reported a catalyst-controlled strategy that efficiently 
manipulated the redox fluidity of o-benzoquinones to form aryl ethers through the coupling 
of o-quinones with phenols under aerobic conditions (Scheme 10).34  
Scheme 10. Lumb’s Cu-Catalyzed Aerobic Coupling of o-Benzoquinones with Phenols 
 
Promoted by molecular oxygen (O2) and a Cu
I/amine catalyst system that “harnesses” the 
reactivity of the o-benzoquinone, the reaction proceeds at room temperature to deliver the 
coupled aryl ether in excellent yields. The modularity of the approach was demonstrated 
across a broad range of phenolic and o-benzoquinone substrates, and various diversification 
reactions of the aryl ether products could be achieved chemoselectively to give an array of 
densely functionalized scaffolds. Extensive screening of the copper salt, amine (ligand), 
copper salt-ligand ratio and solvent revealed the flexible nature of the copper-quinone 
complex. Outlined in Scheme 11, the catalytic cycle begins with a single electron transfer 
between LnCuX and o-benzoquinone 38 to form semiquinone complex 39.  
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Scheme 11. Proposed Mechanism for the Cu-Catalyzed Aerobic Coupling Reaction 
 
Aerobic oxidation of semiquinone 39 generates peroxide 40, which could be trapped with 
phenol—a step that could be described as a formal radical addition. Subsequently, hydrogen 
peroxide is extruded to generate semiquinone 41, followed by the exchange of the LnCuX 
catalyst with o-benzoquinone 38, which allows the release of the product 42.  
Overall, this work demonstrated a simple, mild and selective method to functionalize o-
benzoquinones through a single-electron process—a challenging transformation to achieve 
if reliant on traditional two-electron chemistry. The ability to carefully adjust the reactivity of 
the copper-quinone complex highlights the potential for o-benzoquinones to be utilized in 
catalysis and ligand design.43,44  
There are several total syntheses that have resourcefully used o-benzoquinones to assemble 
the carbon framework of complex natural products, two of which are disclosed below. First, 
Pan and co-workers utilized a one-pot catechol oxidation followed by an intramolecular 1,4-
addition reaction to forge the dibenzofuran framework of (±)-anastatin A (43) (Scheme 12).45 
Scheme 12. Pan’s Total Synthesis of (±)-Anastatin A (43) 
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Several conditions were evaluated to convert catechol 44 to the o-benzoquinone, including 
oxidants Ag2O, MnO2 and K3Fe[CN]6. Ag2O was found to be the superior reagent to effect 
the oxidation-oxa-Michael sequence, affording the desired dibenzofuran catechol (45) in 
75% yield. Interestingly, extending the reaction time resulted in diminished yields due to 
decomposition of the dibenzofuran product presumably caused by Ag2O. A comparable 
observation was made in our total synthesis of boletopsin 11 during the construction of the 
dibenzofuran framework of the natural product, and our approach in resolving this drawback 
will be discussed in Chapter Three. 
Vincent and co-workers’ biomimetic regiodivergent total syntheses of voacalgine A (46) and 
bipleiophylline (47) are a testament to the capacity of o-benzoquinones to engage in domino 
reactions that tactically stitch up intricate heterocyclic frameworks (Scheme 13).46,47 The key 
synthetic strategy features a carefully orchestrated cascade of oxidation and conjugate 
addition reactions employing indole alkaloids and 2,3-dihydroxybenzoic acid  (48) to achieve 
the syntheses of these natural products.  
Scheme 13. Biomimetic Total Synthesis of Voacalgine A (46) and Bipleiophylline (47) 
 
Mechanistically, the domino sequence is believed to proceed via the 1,4-addition of 
pleiocarpamine 49 to the o-benzoquinone 50 generated from the oxidation of 2,3-
dihydroxybenzoic acid (48) with Ag2O (Scheme 14). This is succeeded by the intramolecular 
trapping of the transient indole iminium with the benzoic acid functionality. A second 
oxidation event of the catechol moiety generates the o-benzoquinone form of voacalgine A 
51, which reacts with another unit of pleiocarpamine (49) through a 1,6-addition process, 
followed by intramolecular cyclization to complete the carbon framework of bipleiophylline. 
Completion of the biomimetic synthesis of voacalgine A (46) also enabled the structural 
revision of the natural product. 
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Scheme 14. Mechanistic Proposal for the Formation of Voacalgine A (46) and Bipleiophylline (47) 
 
Vincent’s elegant approach to bipleiophylline (47) represents another example of a creative 
application of o-benzoquinones in total synthesis, and justifies further exploration of this 
underrepresented synthetic building block in the context of complex molecule synthesis.  
Motivations in Designing the Michael-[O]-oxa-Michael Reaction 
At the outset of this work, the conventional routes to access polyoxygenated dibenzofurans 
traversed through multiple steps and typically proceeded through elaborate synthetic 
intermediates. Specifically, existing synthetic approaches used a combination of oxidative 
coupling and intramolecular nucleophilic substitution reactions to forge either the C-O or C-
C bonds of the heterocyclic framework from the biphenyl or diaryl ether precursors—some 
of which are illustrated in Scheme 15.  
Scheme 15. Representative Strategies to Access Polyoxygenated Dibenzofuran Frameworks 
 
Ye and co-workers employed a Cu2O-mediated Ullmann coupling to form the C-O bond of 
the dibenzofuran from the functionalized biphenyl 52 (Scheme 15A).13 Trosien and co-
workers utilized an oxidative approach with MoCl5 to construct the C-C bond of the 
dibenzofuran heterocycle from the diaryl ether precursor (Scheme 15B).48 In 2015, Zhao and 
co-workers disclosed a synthetic strategy that formed the C-O and C-C bonds in a single-pot 
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reaction to assemble functionalized dibenzofuran scaffolds (Scheme 15C).49 A Pd-catalyzed 
cross coupling reaction was utilized to forge the C-C linkage, followed by rearomatization 
and in situ Ullmann coupling to complete the dibenzofuran framework. 
Given our broader interest in the synthesis of p-terphenyl dibenzofuran natural products, we 
sought to formulate an alternative approach whereby the desired dibenzofuran framework 
could be assembled directly from chemical commodities that are readily available. In 
particular, we envisioned an ideal scenario of combining commercially available phenols and 
o-benzoquinones through a Michael-oxidation-oxa-Michael cascade to construct the 
dibenzo[b,d]furan framework in a single step. 
The following paper published in Organic Letters describes a study that explored and harnessed 
the chemistry of o-benzoquinones within the context of dibenzofuran synthesis. The scope 
of the key transformation was showcased with an array of phenol/naphthol coupling 
partners. Moreover, the utility of the methodology was illustrated in the first synthesis of two 
dibenzofuran natural products isolated from the plant Ribes takare.50 Our strategy, which 
assembled the entire molecular framework of the natural products with the appropriate 
oxygenation pattern in a single-pot operation, yielded the natural products in three and five 
steps from readily available starting materials. Mechanistically, we believe that the o-
benzoquinone serves as both the double Michael acceptor and the sacrificial oxidant. Our 
hypothesis was further corroborated experimentally through premature quenching of the 
reaction and isolation of the initial Michael adduct, which upon re-exposure to the reaction 
conditions (i.e. o-benzoquinone) delivered the dibenzofuran framework. 
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ABSTRACT: The construction of polyoxygenated dibenzo-
[b,d]furan frameworks from the union of substituted phenols/
naphthols and o-benzoquinones via a Michael-oxidation-oxa-
Michael cascade is reported. The power of this transformation
is demonstrated in the generation of a library of highly
substituted dibenzofurans, featuring speciﬁcally substituted
molecules containing broad ranges of functionality. The utility
of this method is showcased in the total syntheses of two
dibenzofurans isolated from Ribes takare, assembling the carbon scaﬀold of both natural products in one operation.
Oxygen-rich dibenzofurans are a class of compoundsprevalent in nature.1 Their unique structural features
and promising biological activity have continuously inspired the
synthetic community toward development of methodologies
that have allowed for the preparation of a diverse array of
natural/unnatural products bearing this structural motif.2
Cycloleucomelone (1),3 vialinin B (2),4 boletopsin 13 (3),5
and popolohuanone E (4)6 are examples of bioactive natural
products containing the dibenzofuran/dibenzofuranquinone
substructure. Recently, two novel dibenzofurans 5 and 6
possessing α-glucosidase inhibitory activity were isolated from
the aerial parts of Ribes takare D. Don by Chen et al. (Figure
1).7
Unsurprisingly, the most challenging part of the synthesis of
polyoxygenated dibenzofurans is the construction of the
densely substituted dibenzofuran core. Previous synthetic
routes toward functionalized dibenzofurans have traversed
oxidative couplings and intramolecular nucleophilic substitution
of hydroxylated biphenyl frameworks (or their oxidized
quinone forms).2a,8 The Anderson group presented a base
catalyzed intramolecular condensation toward the construction
of the dibenzofuranquinone core in their biomimetic study of
popolohuanone E (Scheme 1, eq 1).6 In the synthesis of
vialinin B reported by Ye and co-workers, the dibenzofuran
core of the natural product was accessed via copper(I)
Received: March 21, 2017
Published: April 21, 2017
Figure 1. Dibenzofuran natural products.
Scheme 1. Syntheses of Polyoxygenated Dibenzofurans
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mediated Ullmann coupling (Scheme 1, eq 2).4 Pan and co-
workers disclosed a silver(I) oxidation followed by an
intramolecular oxa-Michael addition of the hydroxyl moiety
to the o-benzoquinone in their syntheses of anastatins A and B
(Scheme 1, eq 3).9
We were interested in developing a complementary approach
that would permit access to the dibenzofuran framework
directly from unprotected phenols and o-benzoquinones, rather
than from biphenyl precursors, in a single process. o-
Benzoquinones are well-known for their capricious reactivity,
for example, toward nucleophiles, redox lability, and ability to
act as ligands.10 Nevertheless, promising results have been
reported that exploit o-benzoquinones as powerful building
blocks to rapidly access complex targets, such as various
coumestans and bipleiophylline.11 With the right conditions, we
envisioned that the dibenzofuran framework could be accessed
via the union of phenols and o-benzoquinones in a single
operation through a formal (3 + 2) cycloaddition or Michael-
oxidation-oxa-Michael type process.
The dibenzofuran synthesis was ﬁrst investigated using
sesamol (7a) as the phenolic component, o-benzoquinone (8),
and MeMgCl as the base, as outlined in Table 1. Dibenzofuran
9a was formed in 37% yield using 1.1 equiv of base at −40 °C,
with 43% sesamol recovered (entry 2). Eﬀorts directed at
improving yield proved MeMgCl to be superior over n-BuLi
and NaH, while modiﬁcation of the solvent system including
the use of diethyl ether or toluene/THF (3:1) failed to improve
the product yield. Interestingly, the dearomatized para adduct
10a was observed when the reaction temperature was lowered
to −78 °C (entry 3). Furthermore, the yield of 10a increased
when the reaction temperature was maintained and quenched
at −78 °C (entry 4). Increasing the number of equivalents of o-
benzoquinone enhanced the consumption of sesamol, and
ultimately the yield as determined by NMR was improved to
43% (entry 7). Puriﬁcation of the dibenzofurans presented a
considerable challenge due to the highly polar nature of the
catechol functionality, and use of conventional silica gel
chromatography consistently resulted in 20−25% loss of
product. Among other types of chromatographic supports
used, including alumina and reverse phase silica, gel permeation
chromatography using Sephadex LH-20 was found to be the
most eﬀective, aﬀording dibenzofuran 9a in 40% isolated yield.
With the optimized conditions (Table 1, entry 7) in hand,
the scope of this presumed Michael-oxidation-oxa-Michael
cascade was explored with a diverse collection of phenols.
Initially, the reactivity of various 4-substituted sesamol coupling
partners was investigated. The transformation was tolerant of
functionalities extending from bromide, benzyl, and prenyl
groups, aﬀording the desired dibenzofurans in moderate yields
(Scheme 2, 9b, 9c, and 9d). Similarly, 2,3,4-trimethoxyphenol
reacted with o-benzoquinone to give the desired trimethoxy-
Table 1. Screening of Temperature and Equivalents of o-
Benzoquinonea
yield (%)b
entry t (°C) n 7a 9a 10a
1 −20 1.2 52 31 −c
2 −40 1.2 43 37 4
3 −78 1.2 37 33 18
4d −78 1.2 44 28 25
5 −98 1.2 35 30 14
6 −40 3.6 10 36 8
7e −40 3.6 10 43 (40f) −
aAll reactions were performed with sesamol (0.725 mmol) in 15 mL of
THF, and o-benzoquinone was added in one portion. The reaction was
gradually warmed to room temperature and stirred for 1.5 h unless
otherwise noted. bDetermined by 1H NMR spectroscopy using 1,2-
dichloroethane as an internal standard. cNot detected by 1H NMR
spectroscopy. dReaction mixture was maintained at −78 °C for 1.5 h
and then quenched at −78 °C. eReaction was quenched 0.5 h after
addition of o-benzoquinone. fIsolated yield.
Scheme 2. Scope of Phenolsa
aReactions were performed with phenol/naphthol (1.0 equiv),
MeMgCl (1.1 equiv), and o-benzoquinone (3.6 equiv). Isolated yields
unless otherwise noted. bBased on recovered starting material
(BRSM) yields. cReaction was performed with 3-methoxy-1-naphthol
(1.0 equiv), MeMgCl (1.1 equiv), and o-benzoquinone (1.2 equiv) in
25 mL of THF, and the reaction time was 16 h. dUnreacted phenol/
naphthol and catechol (reduced form of o-benzoquinone) were
observed for reactions where no dibenzofuran formation was detected.
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dibenzofuran catechol 9e in 26% yield. A diminished yield was
observed with 3-methoxy-4-(4-methoxyphenyl)phenol (9f),
and dibenzofuran formation was not observed with 4-methoxy,
3-methoxy, 3,4-dimethyl, or 3-chloro-4-methoxyphenol (7g, 7h,
7i, 7j). The outcomes suggest that the presence of strongly
electron-donating groups (EDGs) on the 3,4-positions of the
phenolic coupling partner are crucial for successful dibenzofur-
an formation.
While competing reactivity of the nucleophile involved in the
initial Michael reaction had been detected previously (Table 1,
entries 3 and 4), we observed exclusive reactivity through C-4
when 3,4,5-trimethoxyphenol or 3-methoxy-1-naphthol were
subjected to the reaction conditions, producing compounds
10k and 10l respectively (Scheme 2). This was remarkable in
the case of 10k, favoring the formation of the dearomatized
cyclohexa-2,5-dien-1-one, indicating a clear preference for
addition at the para carbon in substrates of this nature. We
have also recognized the potential for the reaction to be applied
in the generation of oxygenated biphenyl compounds such as
10l.
The formal (3 + 2) cycloadditions of 1-naphthols with o-
benzoquinone were also examined. Subjecting a range of 1-
naphthols that contain EDGs at the 4-position (methoxy, 4-
methoxyphenyl, 3-ﬂuoro-4-methoxyphenyl, 2-furanyl) to the
optimized reaction conditions furnished the desired dibenzo-
furans 9m, 9n, 9o, and 9p in slightly higher yields compared to
the phenolic coupling counterparts (Scheme 2). However, the
annulation of 4-bromo-1-naphthol (7q) could not be achieved,
reinforcing the necessity of the EDG at the 4-position which
presumably enhances the nucleophilicity of the phenolate. The
union of 2-naphthol 7r and o-benzoquinone was also
unsuccessful. We anticipate this procedure, eﬀectively forming
two bonds and a ring in a single operation, will ﬁnd wide
application and entry into uncharted dibenzofuran chemical
space via simple modiﬁcations of phenols.
The synthetic utility of this methodology was further
highlighted through the ﬁrst syntheses of the dibenzofuran-
containing natural products 5 and 6. As depicted in Scheme 3,
4-methoxydibenzofuran catechols 11 and 12 were constructed
in 41% (56% BRSM) and 38% (61% BRSM) yields
respectively, from common quinone 13, and phenolates 14
and 15. Not only does this reaction forge the entire carbon
skeleton of the natural product in a single operation, it
demonstrates for the ﬁrst time that our annulation protocol is
tolerant of functionalized o-benzoquinones in addition to the
parent compound. In addition, the regioselective nature of the
ﬁrst 1,4-addition at the o-benzoquinone 13 was recognized,
resulting in the formation of 4-methoxydibenzofurans 11 and
12 exclusively. The regioselectivity of this transformation could
be explained by the preferential Michael addition at the more
electrophilic C-5 of quinone 13.
Alkylation of the catechol moiety using dibromomethane and
cesium carbonate produced the trimethoxy natural product 5
while its isopropyl analog 16 was prepared with cesium ﬂuoride
and dibromomethane. Finally, selective cleavage of the
isopropyl group with BCl3 followed by a basic workup readily
aﬀorded the dimethoxy natural product 6. The construction of
the entire heterocyclic framework, possessing the correct
substitution pattern, in a single operation has allowed rapid
access to these natural products.
In an eﬀort to gain mechanistic insight, the sequence of
reactivity was investigated by premature quenching of the
annulation reaction at −40 °C after 0.5 h instead of the usual 6
h. The Michael adduct 17 was isolated in 23% yield (Scheme 3)
supporting a putative mechanism whereby the Michael addition
occurs ﬁrst, forming the C−C biphenyl linkage. The
intermediacy of the biphenyl compound 17 was then examined
by subjecting it to the reaction conditions. A solution of 17 in
THF at 0 °C, under an argon atmosphere, was treated with
MeMgCl (1.1 equiv) followed by cooling the reaction mixture
to −40 °C. Unsurprisingly, dibenzofuran 11 was not observed
in the reaction mixture at this stage. However, after addition of
1.2 equiv of o-benzoquinone 13, approximately 80% conversion
to 11 was observed. These observations support the dual role of
the o-benzoquinone as both the Michael acceptor and oxidant
in the reaction. We propose the mechanism proceeds through
oxidation of the catecholate monoanion in the intermediate
following the initial Michael addition generating an o-quinone
that acts as the oxa-Michael acceptor in the subsequent reaction
in the cascade.
In summary, a new method for the rapid construction of
polyoxygenated dibenzo[b,d]furan scaﬀolds has been devel-
oped. The procedure involves the annulation of readily
available phenols/naphthols with o-benzoquinones which
concisely orchestrates a Michael-oxidation-oxa-Michael se-
quence in a single operation. Successful application of this
method enabled the ﬁrst divergent syntheses of two
dibenzofuran natural products 5 and 6 in three and ﬁve
steps, respectively. Given the prevalence of oxygen-rich
dibenzofurans in nature, we envision that this approach holds
great potential to broaden the accessibility to a diverse
Scheme 3. Application in Total Syntheses of Dibenzofuran
Natural Products 5 and 6 Isolated from Ribes takarea
aDibenzofuran formation: Reactions were performed with phenol (1.0
equiv), MeMgCl (1.3 equiv), and 3-methoxy-o-benzoquinone (1.2
equiv) in 20 mL of THF unless otherwise noted. Isolated yields unless
otherwise noted. bBRSM yields. cReaction was performed with phenol
(1.0 equiv), MeMgCl (1.1 equiv), and 3-methoxy-o-benzoquinone (1.2
equiv) in 20 mL of THF.
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collection of dibenzofuran-containing natural/unnatural com-
pounds.
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GENERAL PROCEDURES 
NMR spectra were recorded at 298 K, 400 MHz for 
1
H, 100 MHz for 
13
C on Avance 400 
instrument. Chemical shifts are reported in ppm (δ). NMR experiments were run in CDCl3, 
(CD3)2CO or CD3OD as indicated, 
1
H NMR spectra are referenced to the resonance from 
residual CHCl3 at 7.26 ppm, CHD2COCD3 at 2.05 ppm and CHD2OD at 3.31 ppm. 
13
C NMR 
spectra are referenced to the central peak in the signal from CDCl3 at 77.0 ppm, (CD3)2CO at 
29.8 ppm and CD3OD at 49.0 ppm. The multiplicities of 
1
H and 
13
C NMR resonances are 
expressed by abbreviations: s (singlet), d (doublet), t (triplet), quartet (q), m (multiplet) and 
combinations thereof for highly coupled systems. 
13
C NMR spectra were run as proton 
decoupled experiments. 
1
H and 
13
C signals where appropriate are described by chemical shift 
δ (multiplicity, J (Hz), integration, assignment).  
EI-MS were recorded on an Agilent HP 6890 series gas GC/MS with a 7683 series injector. 
HREI-MS were recorded on a Waters AutoSpec Premier spectrometer magnetic sector 
instrument, operating at 70 eV. ESI-MS were recorded on a ZMD Micromass spectrometer 
with Waters Alliance 2690 HPLC. HRESI-MS were recorded on a Waters LCT Premier time-
of-flight (TOF) mass spectrometer. Mass spectra are displayed as mass/charge ratios (m/z) 
and relative abundance (% of base peak intensity). 
Thin layer chromatography (TLC) was run on Merck silica gel 60 F254 aluminium backed 
plates and details of the eluents are described in each procedure. Plates were observed under 
UV light (254 nm) and/or developed in ceric phosphomolybdic acid dip (1% aqueous 
solution) followed by heating. Flash column chromatography was run on silica gel (230-400 
mesh) using the eluent system detailed for each procedure. According to standard 
procedures,
1
 all solvents were dried and distilled either immediately prior to use or stored as 
appropriate. IR spectra were recorded on the Alpha Bruker Optics FT-IR spectrometer or the 
PerkinElmer Spectrum Two FT-IR spectrometer (neat) and all data were reported in 
wavenumbers. Peak intensities are described by s (strong), m (medium), w (weak), br 
(broad). 
 
2,3,4-Trimethoxyphenol (7e),
2
 MOM ether 18,
3
 4-bromonaphthalen-1-ol (7q),
4
 4-bromo-3-
methoxyphenol,
5
 3-isopropoxy-4-methoxyphenol
6
 were prepared following literature 
procedures.   
S3 
 
EXPERIMENTAL SECTION 
OPTIMIZATION 
 
o-Benzoquinone (8) 
Catechol (1.00 g, 9.09 mmol, 1.0 equiv) was dissolved in 80 mL CH2Cl2 and stirred at room 
temperature. An aqueous solution of sodium periodate (2.14 g, 10.0 mmol, 1.1 equiv) was 
added in one portion and the biphasic reaction mixture was stirred vigorously for 10 minutes 
at which time the mixture was cooled to 0 °C and kept under an atmosphere of N2. The 
organic layer was separated and washed with water, dried with MgSO4 and concentrated 
under reduced pressure maintaining the temperature at 0 °C, affording the title compound as a 
red solid (745 mg, 6.90 mmol, 76%). The product was found to be unstable and only the 
1
H 
NMR spectrum was obtained. The product was either used immediately or stored at –10 °C 
under an atmosphere of N2. 
1
H NMR (400 MHz, CDCl3): δ 7.04 (m, 2 H, 4-H & 5-H), 6.42 
(m, 2 H, 3-H & 6-H). 
 
Benzo[b][1,3]dioxolo[4,5-f]benzofuran-7,8-diol (9a) 
MeMgCl (2.3 M solution in THF, 0.797 mmol, 1.1 equiv) was added dropwise to a solution 
of sesamol (7a) (100 mg, 0.725 mmol, 1.0 equiv) in 15 mL THF at 0 °C under N2. After 30 
minutes, the reaction mixture was cooled to –40 °C and o-benzoquinone (8) (282 mg, 2.61 
mmol, 3.6 equiv) was added in one portion. After 30 minutes, water and saturated NH4Cl 
solution was added. The mixture was extracted with Et2O and the organic layers were washed 
with brine, dried with MgSO4 and concentrated under reduced pressure. Purification was 
achieved using gel permeation chromatography (GPC) (Sephadex LH-20, MeOH 100%) 
affording the title compound as a beige foam (70.8 mg, 0.290 mmol, 40%). As mentioned in 
the manuscript, when the reaction was perform at –78 °C and –98 °C, the para adduct 10a 
was also isolated. Rf (2:1 Et2O/petroleum spirits (pet.)) = 0.35. IR: ν (cm
-1
) = 3472 (br), 1471 
S4 
 
(s), 1277 (s), 1136 (s). 
1
H NMR (400 MHz, (CD3)2CO): δ 8.09 (br, 2 H, 7-OH & 8-OH), 7.35 
(s, 1 H), 7.32 (s, 1 H), 7.07 (s, 1 H), 7.03 (s, 1 H), 6.04 (s, 2 H, 2-H). 
13
C NMR (100 MHz, 
(CD3)2CO): δ 152.1 (5a-C), 151.8, 147.5, 145.8, 145.0, 142.9, 118.7, 117.1, 105.6, 102.4 (2-
C), 99.6, 99.1, 94.5. ESI-MS: 243 (100, [M]
–
 C13H7O5). HRESI-MS: Found m/z of 243.0296 
(calculated for C13H7O5 [M–H]
–
 243.0293). 
 
7a-(3,4-Dihydroxyphenyl)benzo[d][1,3]dioxol-5(7aH)-one (10a) 
Rf (2:1 Et2O/pet.) = 0.15. IR: ν (cm
-1
) = 3472 (br), 1471 (s), 1277 (s), 1136 (s). 
1
H NMR (400 
MHz, (CD3)2CO): δ 8.18 (br, 2 H, 3’-OH & 4’-OH), 7.14 (d, J = 9.7 Hz, 1 H, 7-H), 6.93 (m, 
1 H, 2’-H), 6.85 (m, 2 H, 5’-H & 6’-H), 5.92 (dd, J = 9.7, 1.4 Hz, 1 H, 6-H), 5.73 (d, J = 0.7 
Hz, 1 H, 2A-H), 5.66 (d, J = 1.4 Hz, 1 H, 4-H), 5.25 (d, J = 0.7 Hz, 1 H, 2B-H). 
13
C NMR 
(100 MHz, (CD3)2CO): δ 187.9 (5-C), 173.4 (3a-C), 146.9, 146.5, 142.0 (7-C), 128.3 (6-C), 
127.5 (1’-C), 118.1, 116.7, 113.4 (2’-C), 99.8 (4-C), 98.5 (2-C), 82.6 (1a-C). ESI-MS: 245 (9, 
[M–H]
– 
 C13H9O5), 215 (100). HRESI-MS: Found m/z of 245.0447 (calculated for C13H9O5 
[M–H]
–
 245.0450). 
 
REPRESENTATIVE REACTION PROCEDURE ON 1.04 mmol SCALE 
 
 
Benzo[b][1,3]dioxolo[4,5-f]benzofuran-7,8-diol (9a) 
MeMgCl (2.5 M solution in THF, 1.15 mmol, 1.1 equiv) was added dropwise to a solution of 
sesamol (7a) (144 mg, 1.04 mmol, 1.0 equiv) in 20 mL THF at 0 °C under N2. After 30 
minutes, the reaction mixture was cooled to –40 °C and o-benzoquinone (8) (406 mg, 3.76 
mmol, 3.6 equiv) was added in one portion. After 30 minutes, water and saturated NH4Cl 
solution were added. The mixture was extracted with Et2O and the organic layers were 
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washed with brine, dried with MgSO4 and concentrated under reduced pressure. Purification 
was achieved using gel permeation chromatography (GPC) (Sephadex LH-20, MeOH 100%) 
affording the title compound as a beige foam (111 mg, 0.455 mmol, 44%).  
 
SCOPE STUDY 
The following compounds were prepared in a similar manner to dibenzofuran 9a. 
 
4-Bromobenzo[b][1,3]dioxolo[4,5-f]benzofuran-7,8-diol (9b) 
Beige foam (82.8 mg, 0.256 mmol, 37%) from phenol 7b (164 mg, 0.759 mmol, 1.0 equiv) 
and o-benzoquinone (8) (295 mg, 2.73 mmol, 3.6 equiv). Rf (2:1 Et2O/pet.) = 0.31. IR: ν (cm
-
1
) = 3383 (br), 1463 (m), 1445 (s), 1278 (s), 1173 (m), 1134 (s), 1046 (s). 
1
H NMR (400 
MHz, (CD3)2CO): δ 8.23 (br, 2 H, 7-OH & 8-OH), 7.36 (s, 1 H), 7.33 (s, 1 H), 7.10 (s, 1 H), 
6.15 (s, 2 H, 2-H). 
13
C NMR (100 MHz, (CD3)2CO): δ 151.7, 149.3 (4a-C), 146.3, 145.8, 
145.3, 143.4, 119.5, 117.1, 105.9, 103.1 (2-C), 99.2, 98.9 (10-C), 85.8 (4-C). ESI-MS: 321 
(100, [M–H]
–
 C13H6
79
BrO5), 323 (98, [M+2–H]
–
 C13H6
81
BrO5). HRESI-MS: Found m/z of 
320.9403 (calculated for C13H6
79
BrO5 [M–H]
–
 320.9399). 
 
4-Benzylbenzo[b][1,3]dioxolo[4,5-f]benzofuran-7,8-diol (9c) 
Beige foam (102 mg, 0.307 mmol, 42%) from phenol 7c (165 mg, 0.725 mmol, 1.0 equiv) 
and o-benzoquinone (8) (282 mg, 2.61 mmol, 3.6 equiv). Rf (2:1 Et2O/pet.) = 0.32. IR: ν (cm
-
1
) = 3374 (br), 1471 (m), 1443 (s), 1132 (s), 1052 (s). 
1
H NMR (400 MHz, (CD3)2CO): δ 8.10 
(br, 2 H, 7-OH & 8-OH), 7.37-7.35 (m, 2 H, 2’-H), 7.34 (s, 1 H), 7.27-7.23 (m, 2 H, 3’-H), 
7.21 (s, 1 H, 10-H), 7.17-7.14 (m, 1 H, 4’-H), 7.06 (s, 1 H), 6.05 (s, 2 H, 2-H), 4.19 (s, 2 H, 4-
CH2Ph). 
13
C NMR (100 MHz, (CD3)2CO): δ 151.8, 150.9 (5a-C), 145.7, 145.5, 144.8, 142.9, 
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140.5 (1’-C), 129.28, 129.23, 127.0 (4’-C), 118.4, 117.5, 108.8, 105.7, 102.4 (2-C), 99.2, 
97.7, 30.5 (4-CH2C6H5). ESI-MS: 333 (100, [M–H]
– 
 C20H13O5). HRESI-MS: Found m/z of 
333.0764 (calculated for C20H13O5 [M–H]
–
 333.0763). 
 
4-(3-Methylbut-2-en-1-yl)benzo[b][1,3]dioxolo[4,5-f]benzofuran-7,8-diol (9d) 
Beige foam (95.8 mg, 0.307 mmol, 42%) from phenol 7d (149 mg, 0.725 mmol, 1.0 equiv) 
and o-benzoquinone (8) (282 mg, 2.61 mmol, 3.6 equiv). Rf (2:1 Et2O/pet.) = 0.30. IR: ν (cm
-
1
) = 3383 (br), 1465 (m), 1442 (s), 1273 (s), 1132 (s), 1054 (s). 
1
H NMR (400 MHz, 
(CD3)2CO): δ 8.06 (br, 2 H, 7-OH & 8-OH), 7.33 (s, 1 H), 7.16 (s, 1 H, 10-H), 7.06 (s, 1 H), 
6.02 (s, 2 H, 2-H), 5.39 (m, 1 H, 2’-H), 3.53 (d, J = 7.3 Hz, 2 H, 1’-H), 1.80 (s, 3 H), 1.67 (s, 
3 H). 
13
C NMR (100 MHz, (CD3)2CO): δ 151.7, 150.9 (3a-C), 145.6, 145.1 (1a-C), 144.8 (5a-
C), 142.8, 133.3 (3’-C), 121.8 (2’-C), 118.3, 117.5, 109.2 (4-C), 105.7, 102.2 (2-C), 99.1, 
97.2 (10-C), 25.8 (3’-CH3 (trans)), 23.8 (1’-C), 17.9 (3’-CH3 (cis)). ESI-MS: 311 (100, [M–
H]
– 
 C18H15O5). HRESI-MS: Found m/z of 311.0919. (calculated for C18H15O5 [M–H]
–
 
311.0919). 
 
6,7,8-Trimethoxydibenzo[b,d]furan-2,3-diol (9e) 
Beige foam (55.6 mg, 0.192 mmol, 26% isolated yield, 20% phenol 7e recovered) from 
phenol 7e (133 mg, 0.725 mmol, 1.0 equiv) and o-benzoquinone (8) (282 mg, 2.61 mmol, 3.6 
equiv). Rf (2:1 Et2O/pet.) = 0.12. IR: ν (cm
-1
) = 3384 (br), 1471 (s), 1426 (s), 1288 (s), 1140 
(s), 1042 (m). 
1
H NMR (400 MHz, (CD3)2CO): δ 8.15 (br, 2 H, 2-OH & 3-OH), 7.39 (s, 1 H), 
7.22 (s, 1 H, 5-H), 7.07 (s, 1 H), 4.12 (s, 3 H, 8-OCH3), 3.90 (s, 3 H, 6-OCH3), 3.83 (s, 3 H, 
7-OCH3). 
13
C NMR (100 MHz, (CD3)2CO): δ 151.9, 151.6 (6-C), 146.5, 143.5 (9a-C), 143.0, 
141.2 (7-C), 140.1 (8-C), 121.6, 116.9, 106.1, 99.1, 97.8 (5-C), 61.5 (7-OCH3), 61.3 (8-
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OCH3), 56.9 (6-OCH3). ESI-MS: 289 (100, [M–H]
– 
 C15H13O6). HRESI-MS: Found m/z of 
289.0714. (calculated for C15H13O6 [M–H]
–
 289.0712) 
.  
7-Methoxy-8-(4-methoxyphenyl)dibenzo[b,d]furan-2,3-diol (9f) 
Beige flaky solid (23.8 mg, 0.0708 mmol, 11% isolated yield, 35% phenol 7f recovered) from 
phenol 7f (153 mg, 0.664 mmol, 1.0 equiv) and o-benzoquinone (8) (258 mg, 2.39 mmol, 3.6 
equiv). Rf (2:1 Et2O/pet.) = 0.18. IR: ν (cm
-1
) = 3393 (br), 1611 (s), 1478 (m), 1286 (m), 1246 
(m), 1134 (s). 
1
H NMR (400 MHz, (CD3)2CO): δ 8.11 (br, 2 H, 2-OH & 3-OH), 7.73 (s, 1 H, 
9-H), 7.48 (m, 2 H, 2’-H), 7.42 (s, 1 H), 7.24 (s, 1 H, 6-H), 7.07 (s, 1 H), 6.98 (m, 2 H, 3’-H), 
3.88 (s, 3 H, 7-OCH3), 3.84 (s, 3 H, 4’-OCH3). 
13
C NMR (100 MHz, (CD3)2CO): δ 159.6 (4’-
C), 157.4 (5a-C), 156.7 (7-C), 151.6, 145.9, 143.0, 132.3 (1’-C), 131.7 (2’-C), 127.1 (8-C), 
121.7 (9-C), 118.6, 116.7, 114.2 (3’-C), 106.0, 99.2, 96.0 (6-C), 56.4 (7-OCH3), 55.5 (4’-
OCH3). ESI-MS: 335 (100, [M–H]
– 
 C20H15O5). HRESI-MS: Found m/z of 335.0927. 
(calculated for C20H15O5 [M–H]
–
 335.0919). 
  
3',4'-Dihydroxy-1,2,6-trimethoxy-[1,1'-biphenyl]-4(1H)-one (10k) 
Beige foam (125 mg, 0.429 mmol, 59%) from 3,4,5-trimethoxyphenol (7k) (133 mg, 0.725 
mmol, 1.0 equiv) and o-benzoquinone (8) (282 mg, 2.61 mmol, 3.6 equiv). Rf (4:1 Et2O/pet.) 
= 0.04. IR: ν (cm
-1
) = 3196 (br), 1650 (s), 1588 (s), 1364 (m), 1244 (s), 1212 (s), 1085 (s). 
1
H 
NMR (400 MHz, (CD3)2CO): δ 7.87 (br, 2 H, 3’-OH & 4’-OH), 6.94 (dd, J = 1.6, 0.6 Hz, 1 
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H, 2’-H), 6.77-6.72 (m, 2 H, 5’-H & 6’-H), 5.60 (s, 2 H, 3-H), 3.65 (s, 6 H, 2-OCH3), 3.19 (s, 
3 H, 1-OCH3). 
13
C NMR (100 MHz, (CD3)2CO): δ 187.1 (4-C), 171.6 (2-C), 145.6, 145.4, 
131.3 (1’-C), 117.9, 115.6, 113.9 (2’-C), 103.7 (3-C), 80.2 (1-C), 56.5 (2-OCH3), 52.5 (1-
OCH3). ESI-MS: 291 (100, [M–H]
– 
 C15H15O6). HRESI-MS: Found m/z of 291.0863. 
(calculated for C15H15O6 [M–H]
–
 291.0869). 
2'
4'
OH
O
4
1
OH
OH
10l
 
4-(4-Hydroxy-2-methoxynaphthalen-1-yl)benzene-1,2-diol (10l) 
This compound was prepared with a modified procedure in the interests of easier separation 
of the desired product. MeMgCl (2.0 M solution in THF, 1.27 mmol, 1.1 equiv) was added 
dropwise to a solution of 3-methoxynaphthalen-1-ol (7l) (200 mg, 1.15 mmol, 1.0 equiv) in 
10 mL THF at 0 °C under N2. After 30 minutes, the solution was transferred dropwise to a 
solution of o-benzoquinone (8) (149 mg, 1.38 mmol, 1.2 equiv) in 15 mL THF at –40 °C. The 
flask was slowly warmed to room temperature and stirred for 16 hours at which time water 
and 1 M HCl solution was added. The mixture was extracted with Et2O and the organic layers 
were washed with brine, dried with MgSO4 and concentrated under reduced pressure. 
Purification was achieved using flash column chromatography on silica using Et2O/pet. = 5:1 
as the eluent followed by trituration using CH2Cl2 and petroleum ether, affording the title 
compound as a beige foam (113 mg, 0.403 mmol, 35%). Rf (4:1 Et2O/pet.) = 0.18. IR: ν (cm
-
1
) = 3340 (br), 1686 (s), 1586 (s), 1516 (s), 1359 (s), 1239 (s), 1202 (s), 1070 (s). 
1
H NMR 
(400 MHz, (CD3)2CO): δ 8.20 (d, J = 8.6 Hz, 1 H, 5’-H), 7.51 (d, J = 8.6 Hz, 1 H, 8’-H), 7.32 
(m, 1 H, 7’-H), 7.27 (m, 1 H, 6’-H), 6.94 (d, J = 8.0 Hz, 1 H, 6-H), 6.91 (s, 1 H, 3’-H), 6.80 
(d, J = 1.9 Hz, 1 H, 3-H), 6.63 (dd, J = 1.9, 8.0 Hz, 1 H, 5-H), 3.73 (s, 3 H, 2’-OCH3). 
13
C 
NMR (100 MHz, (CD3)2CO): δ 155.3 (2’-C), 154.5 (4’-C), 145.5 (2-C), 144.7 (1-C), 135.6 
(8’a-C), 129.3 (4-C), 127.3 (7’-C), 125.8 (8’-C), 123.9 (5-C), 122.9 & 122.8 (5’-C & 6’-C), 
121.3 (4’a-C), 119.4 (3-C), 118.0 (1’-C), 115.8 (6-C), 98.3 (3’-C), 56.8 (2’-OCH3). EI-MS: 
282 (100, [M]
+•
 C17H4O4). HREI-MS: Found m/z of 282.0890. (calculated for C17H14O4 [M]
+•
 
282.0892). 
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5-Methoxynaphtho[1,2-b]benzofuran-8,9-diol (9m) 
Beige foam (116 mg, 0.414 mmol, 57%) from naphthol 7m (126 mg, 0.725 mmol, 1.0 equiv) 
and o-benzoquinone (8) (282 mg, 2.61 mmol, 3.6 equiv). Rf (2:1 Et2O/pet.) = 0.30. IR: ν (cm
-
1
) = 3370 (br), 1484 (m), 1458 (m), 1377 (m), 1310 (m), 1271 (m), 1140 (s), 1116 (s). 
1
H 
NMR (400 MHz, (CD3)2CO): δ 8.41 (br, 2 H, 8-OH & 9-OH), 8.31 (d, J = 8.4 Hz, 1 H, 4-H), 
8.26 (d, J = 8.2 Hz, 1 H, 1-H), 7.65 (m, 1 H, 2-H), 7.53 (s, 1 H), 7.51 (m, 1 H, 3-H), 7.45 (s, 1 
H, 6-H), 7.24 (s, 1 H), 4.09 (s, 3 H, 5-OCH3). 
13
C NMR (100 MHz, (CD3)2CO): δ 152.8 (5-
C), 151.6, 146.7 (1b-C), 146.5, 143.2, 127.8 (2-C), 125.5 (3-C), 125.1 (4a-C), 123.9 (4-C), 
122.6 (1a-C), 120.7 (1-C), 120.3, 118.0, 105.9, 99.3, 96.9 (6-C), 56.3 (5-OCH3). ESI-MS: 
279 (100, [M–H]
– 
 C17H11O4). HRESI-MS: Found m/z of 279.0648. (calculated for C17H11O4 
[M–H]
–
 279.0657). 
 
5-(4-Methoxyphenyl)naphtho[1,2-b]benzofuran-8,9-diol (9n) 
Beige foam (114 mg, 0.319 mmol, 44%) from naphthol 7n (181 mg, 0.725 mmol, 1.0 equiv) 
and o-benzoquinone (8) (282 mg, 2.61 mmol, 3.6 equiv). Rf (2:1 Et2O/pet.) = 0.32. IR: ν (cm
-
1
) = 3384 (br), 1513 (s), 1468 (s), 1346 (m), 1244 (s), 1129 (s), 1044 (m). 
1
H NMR (400 
MHz, (CD3)2CO): δ 8.40 (d, J = 8.3 Hz, 1 H), 8.29 (br, 2 H, 8-OH & 9-OH), 7.94 (d, J = 8.6 
Hz, 1 H), 7.89 (s, 1 H, 6-H), 7.66 (m, 1 H), 7.56 (s, 1 H), 7.52-7.46 (m, 3 H), 7.27 (s, 1 H), 
7.12 (m, 2 H, 3’-H), 3.91 (s, 3 H, 4’-OCH3). 
13
C NMR (100 MHz, (CD3)2CO): δ 160.1 (4’-
C), 151.59, 151.58, 146.8, 143.5, 136.2 (5-C), 134.0 (1’-C), 132.2 (2’-C), 131.4 (4a-C), 
127.7, 127.2, 126.2, 122.3 (1a-C), 121.2, 120.4, 119.9 (6-C), 117.3, 114.6 (3’-C), 106.1, 99.3, 
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55.7 (4’-OCH3). ESI-MS: 355 (100, [M–H]
– 
 C23H15O4). HRESI-MS: Found m/z of 355.0971. 
(calculated for C23H15O4 [M–H]
–
 355.0970). 
 
5-(3-Fluoro-4-methoxyphenyl)naphtho[1,2-b]benzofuran-8,9-diol (9o) 
Beige foam (103 mg, 0.276 mmol, 38% isolated yield, 16% phenol recovered) from naphthol 
7o (194 mg, 0.725 mmol, 1.0 equiv) and o-benzoquinone (8) (282 mg, 2.61 mmol, 3.6 equiv). 
Rf (2:1 Et2O/pet.) = 0.33. IR: ν (cm
-1
) = 3384 (br), 1688 (m), 1517 (s), 1295 (s), 1266 (s), 
1140 (s). 
1
H NMR (400 MHz, CD3OD): δ 8.36 (d, J = 8.2 Hz, 1 H, 1-H), 7.88 (d, J = 8.4Hz, 
1 H, 4-H), 7.79 (s, 1 H, 6-H), 7.60 (dd, J = 8.2, 7.1 Hz, 1 H, 2-H), 7.45 (dd, J = 7.1, 8.4 Hz, 1 
H, 3-H), 7.38 (s, 1 H), 7.26-7.21 (m, 3 H, 2’-H & 5’-H & 6’-H), 7.16 (s, 1 H), 3.97 (s, 3 H, 
4’-OCH3). 
13
C NMR (100 MHz, CD3OD): δ 153.4 (d, J = 240 Hz, 3’-C), 152.3 (1b-C), 152.1, 
148.4 (d, J = 10 Hz, 4’-C), 147.3, 144.0, 135.43, 135.38, 131.5 (4a-C), 127.6 (4-C), 127.4 (d, 
J = 3 Hz, 6’-C), 127.3 (2-C), 126.5 (3-C), 122.7 (1a-C), 121.5 (1-C), 120.7, 120.1 (6-C), 
118.9 (d, J = 18 Hz, 2’-C), 117.5, 114.7 (d, J = 2 Hz, 5’-C), 105.9, 99.4, 56.9 (4’-OCH3). 
ESI-MS: 373 (100, [M–H]
– 
 C23H14FO4). HRESI-MS: Found m/z of 373.0881. (calculated for 
C23H14FO4 [M–H]
–
 373.0876). 
 
5-(Furan-2-yl)naphtho[1,2-b]benzofuran-8,9-diol (9p) 
Beige foam (129 mg, 0.408 mmol, 53%) from naphthol 7p (162 mg, 0.771 mmol, 1.0 equiv) 
and o-benzoquinone (8) (299 mg, 2.78 mmol, 3.6 equiv). Rf (2:1 Et2O/pet.) = 0.36. IR: ν (cm
-
1
) = 3368 (br), 1469 (m), 1344 (s), 1129 (s). 
1
H NMR (400 MHz, (CD3)2CO): δ 8.42 (d, J = 
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8.0 Hz, 1 H, 4-H), 8.40 (d, J = 7.8 Hz, 1 H, 1-H), 8.33 (br, 2 H, 8-OH & 9-OH), 8.22 (s, 1 H, 
6-H), 7.79 (dd, J = 1.9, 0.6 Hz, 1 H, 5’-H), 7.69 (dd, J = 7.8, 7.1 Hz, 1 H, 2-H), 7.61 (s, 1 H), 
7.59 (dd, J = 8.0, 7.1 Hz, 1 H, 3-H), 7.29 (s, 1 H), 6.82 (dd, J = 3.3, 0.6 Hz, 1 H, 3’-H), 6.68 
(dd, J = 3.3, 1.9 Hz, 1 H, 4’-H). 
13
C NMR (100 MHz, (CD3)2CO): δ 154.4 (2’-C), 152.3 (1b-
C), 151.7, 147.0, 143.6, 143.5 (5’-C), 130.2 (4a-C), 127.5 (2-C), 127.2 (4-C), 126.9 (3-C), 
125.1 (5-C), 122.3 (1a-C), 121.3 (1-C), 120.4, 119.9 (6-C), 117.1, 112.3 (4’-C), 109.9 (3’-C), 
106.2, 99.4. ESI-MS: 315 (100, [M–H]
– 
 C20H11O4). HRESI-MS: Found m/z of 315.0681. 
(calculated for C20H11O4 [M–H]
–
 315.0657). 
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SYNTHESES OF DIBENZOFURAN NATURAL PRODUCTS 
Ag2O, Et2O, MgSO4
rt, 30 min
97%
3
O
O
13
OH
OH
OO
 
3-Methoxycyclohexa-3,5-diene-1,2-dione (13) 
Silver(I) oxide (542 mg, 2.34 mmol, 3.3 equiv) was added to a suspension of 3-
methoxycatechol (100 mg, 0.714 mmol, 1.0 equiv) and MgSO4 (2.20 g) under N2 at room 
temperature. 30 minutes later, the mixture was filtered, washed with CH2Cl2 and concentrated 
under reduced pressure at 0 °C. The dark red solid was utilized immediately in the 
subsequent reaction and kept at –40 °C (96.0 mg, 0.696 mmol, 97%). The product was found 
to be unstable and only the 
1
H NMR spectrum was obtained. 
1
H NMR (400 MHz, CDCl3): δ 
7.04 (dd, J = 10.0, 7.2 Hz, 1 H, 5-H), 6.10 (d, J = 10.0 Hz, 1 H, 4-H), 5.93 (d, J = 7.2 Hz, 1 
H, 6-H), 3.79 (s, 3 H, 3-OCH3). 
 
4,7,8-Trimethoxydibenzo[b,d]furan-2,3-diol (11) 
MeMgCl (2.5 M solution in THF, 0.776 mmol, 1.3 equiv) was added to a solution of 3,4-
dimethoxyphenol (92.0 mg, 0.597 mmol, 1.0 equiv) in 5 mL THF at 0 °C under N2. 0.5 hours 
later, the solution was slowly transferred to a solution of o-benzoquinone 13 (96.0 mg, 0.696 
mmol, 1.2 equiv) in 15 mL THF at –40 °C and stirred at that temperature for one hour at 
which time the flask was warmed to room temperature and stirred for an additional five 
hours. Water and saturated NH4Cl solution was added and extracted with Et2O. The organic 
layers were washed with brine, dried with MgSO4 and concentrated under reduced pressure. 
Purification was achieved using GPC (Sephadex LH-20, MeOH 100%) affording the title 
compound as a beige foam (70.9 mg, 0.244 mmol, 41% isolated mass, 27% 3,4-
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dimethoxyphenol recovered). Rf (2:1 Et2O/pet.) = 0.21. IR: ν (cm
-1
) = 3400 (br), 1482 (s), 
1283 (s), 1147 (s). 
1
H NMR (400 MHz, (CD3)2CO): δ7.79 (br, 2 H, 2-OH & 3-OH), 7.45 (s, 1 
H), 7.21 (s, 1 H), 7.12 (s, 1 H, 1-H), 4.11 (s, 3 H, 4-OCH3), 3.90 (s, 3 H), 3.88 (s, 3 H). 
13
C 
NMR (100 MHz, (CD3)2CO): δ 151.8 (5a-C), 150.1, 147.5, 143.8, 143.1, 137.0, 134.1 (4-C), 
117.8, 117.2, 103.7, 100.1 (1-C), 97.0, 61.0 (4-OCH3), 56.8, 56.5. ESI-MS: 289 (100, [M–
H]
– 
 C15H13O6). HRESI-MS: Found m/z of 289.0715. (calculated for C15H13O6 [M–H]
–
 
289.0712). 
 
4,7,8-Trimethoxybenzo[b][1,3]dioxolo[4,5-f]benzofuran (5) 
Cs2CO3 (48.1 mg, 0.147 mmol, 1.5 equiv), dibenzofuran 11 (28.5 mg, 0.0983 mmol, 1.0 
equiv) and dibromomethane (85.5 mg, 0.492 mmol, 5.0 equiv) were suspended in 1 mL 
degassed DMF and the mixture was stirred at room temperature for one hour at which time 
the flask was heated to 30 °C and stirred for a further three hours. The solvent was removed 
in vacuo and the residue was diluted with Et2O and saturated NH4Cl solution, and extracted 
with Et2O. The organic layers were washed with brine, dried with MgSO4 and concentrated 
under reduced pressure. Purification was achieved via flash column chromatography on silica 
using Et2O/pet = 2:1 as the eluent affording the title compound as a colorless waxy solid. 
(14.2 mg, 0.0470 mmol, 48%).  
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Table 1 – Comparison of 
1
H NMR spectroscopic data for the natural product and synthetic 
sample 5 (in CDCl3) 
natural sample
7
 
δ (ppm), 600 MHz 
synthetic sample (5) 
δ (ppm), 400 MHz 
7.21 (s, 1 H) 7.21 (s, 1 H) 
7.10 (s, 1 H) 7.10 (s, 1 H) 
6.91 (s, 1 H) 6.91 (s, 1 H) 
6.00 (s, 2 H) 6.00 (s, 2 H) 
4.24 (s, 3 H) 4.24 (s, 3 H) 
3.97 (s, 3 H) 3.97 (s, 3 H) 
3.95 (s, 3 H) 3.95 (s, 3 H) 
 
Table 2 - Comparison of 
13
C NMR spectroscopic data for the natural product and synthetic 
sample 5 (in CDCl3) 
natural sample
7
 
δ (ppm), 150 MHz 
synthetic sample (5) 
δ (ppm), 100 MHz 
151.3 151.3 
148.9 148.8 
146.3 146.2 
145.6 145.5 
142.9 142.8 
135.3 135.3 
130.3 130.3 
119.0 119.0 
116.2 116.2 
101.7 101.7 
101.5 101.5 
95.9 95.8 
92.5 92.5 
60.4 60.4 
56.6 56.5 
56.3 56.3 
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Compound 12 was prepared in a similar manner to compound 11. 
 
7-Isopropoxy-4,8-dimethoxydibenzo[b,d]furan-2,3-diol (12) 
Beige foam (72.0 mg, 0.226 mmol, 38% isolated yield, 39% 3-isopropoxy-4-methoxyphenol 
recovered) from 3-isopropoxy-4-methoxyphenol (109 mg, 0.597 mmol, 1.0 equiv). Rf (2:1 
Et2O/pet.) = 0.18. IR: ν (cm
-1
) = 3398 (br), 1478 (s), 1457 (m), 1281 (s), 1147 (s), 1104 (s), 
1015 (m). 
1
H NMR (400 MHz, (CD3)2CO): δ 7.81 (br, 2 H, 2-OH & 3-OH), 7.46 (s, 1 H), 
7.19 (s, 1 H), 7.11 (s, 1 H, 1-H), 4.63 (septet, J = 6.0 Hz, 1 H, 7-OCH(CH3)2), 4.10 (s, 3 H, 4-
OCH3), 3.88 (s, 3 H, 8-OCH3), 1.34 (d, J = 6.0 Hz, 6 H, 7-OCH(CH3)2). 
13
C NMR (100 MHz, 
(CD3)2CO): δ 151.7 (5a-C), 148.9 (8-C), 147.9 (7-C), 143.8, 143.2, 137.1, 134.1 (4-C), 118.1, 
117.8, 104.3, 101.2, 100.2 (1-C), 72.5 (7-OCH(CH3)2), 61.0 (4-OCH3), 57.0 (8-OCH3), 22.4 
(7-OCH(CH3)2). ESI-MS: 317 (28, [M–H]
– 
 C17H17O6), 274 (100). HRESI-MS: Found m/z of 
317.1027. (calculated for C17H17O6 [M–H]
–
 317.1025).  
 
7-Isopropoxy-4,8-dimethoxybenzo[b][1,3]dioxolo[4,5-f]benzofuran (16) 
CsF (20.2 mg, 0.133 mmol, 2.0 equiv), dibenzofuran 12 (21.1 mg, 0.0664 mmol, 1.0 equiv) 
and dibromomethane (57.7 mg, 0.332 mmol, 5.0 equiv) were suspended in 1 mL degassed 
DMF and the mixture was stirred 40 °C for two hours at which time additional CsF (10.1 mg, 
0.0664 mmol, 1.0 equiv) and dibromomethane (28.9 mg, 0.166 mmol, 2.5 equiv) were added 
to the reaction and stirred at 40 °C for one hour. The reaction was cooled to room 
temperature and diluted with Et2O and saturated K2CO3 solution. The mixture was extracted 
with Et2O, washed with saturated K2CO3 solution, dried with MgSO4 and the solvent was 
removed in vacuo. Purification was achieved via flash column chromatography on silica 
S16 
using a gradient elution of Et2O/pet = 1:1 to 2:1, affording the title compound as a colorless 
waxy solid. (8.0 mg, 0.024 mmol, 36%). Rf (1:1 Et2O/pet.) = 0.44. IR: ν (cm
-1
) = 2976 (w),
1626 (w), 1477 (s), 1441 (s), 1276 (s), 1148 (m), 1049 (m). 
1
H NMR (400 MHz, CDCl3): δ
7.22 (s, 1 H), 7.12 (s, 1 H), 6.91 (s, 1 H, 10-H), 6.00 (s, 2 H, 2-H), 4.57 (septet, J = 6.1 Hz, 1 
H, 7-OCH(CH3)2), 4.24 (s, 3 H, 4-OCH3), 3.94 (s, 3 H, 8-OCH3), 1.42 (d, J = 6.1 Hz, 6 H, 7-
OCH(CH3)2). 
13
C NMR (100 MHz, CDCl3): δ 151.3 (6a-C), 147.6, 147.0, 145.5, 143.0 (5a-
C), 135.3, 130.3 (4-C), 119.0, 116.8, 102.4, 101.5 (2-C), 99.9, 92.5 (10-C), 72.1 (7-
OCH(CH3)2), 60.4 (4-OCH3), 56.8 (8-OCH3), 22.0 (7-OCH(CH3)2). EI-MS: 330 (45, [M]
+•
C18H18O6), 288 (100), 273 (76). HREI-MS: Found m/z of 330.1103 (calculated for C18H18O6 
[M]
+•
 330.1103).
4,8-Dimethoxybenzo[b][1,3]dioxolo[4,5-f]benzofuran-7-ol (6) 
Boron trichloride (1.0 M solution in CH2Cl2, 27.3 mmol, 1.5 equiv.) was added dropwise to a 
solution of dibenzofuran 16 (6.00 mg, 0.0182 mmol, 1.0 equiv.) in 1.6 mL CH2Cl2 at –5 °C 
under argon. 10 minutes later, the mixture was quenched with saturated aqueous K2CO3 
solution and extracted with Et2O. The combined organic layers were dried with MgSO4 and 
concentrated under reduced pressure. Purification was achieved via flash column 
chromatography on silica using Et2O/pet. = 1:1 as the eluent affording the title compound as 
a colorless solid (3.20 mg, 0.0111 mmol, 61%).  
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Table 3 – Comparison of 
1
H NMR spectroscopic data for the natural product and synthetic
sample 6 (in CDCl3) 
natural sample
7
 
δ (ppm), 600 MHz 
synthetic sample (6) 
δ (ppm), 400 MHz 
7.18 (s, 1 H) 7.19 (s, 1 H) 
7.13 (s, 1 H) 7.14 (s, 1 H) 
6.89 (s, 1 H) 6.90 (s, 1 H) 
5.99 (s, 2 H) 6.00 (s, 2 H) 
5.99 (s, 1 H, 7-OH) 5.86 (s, 1 H, 7-OH) 
4.23 (s, 3 H) 4.24 (s, 3 H) 
3.99 (s, 3 H) 3.99 (s, 3 H) 
Table 4 - Comparison of 
13
C NMR spectroscopic data for the natural product and synthetic
sample 6 (in CDCl3) 
natural sample
7
δ (ppm), 150 MHz 
synthetic sample (6) 
δ (ppm), 100 MHz 
151.8 151.5 
145.5 145.5 
145.4 145.3 
143.9 143.8 
142.8 142.8 
135.2 135.2 
130.3 130.3 
119.1 119.0 
116.1 116.1 
101.5 101.5 
101.0 100.9 
98.5 98.4 
92.3 92.3 
60.4 60.4 
56.6 56.6 
S18 
4,5,5'-Trimethoxy-[1,1'-biphenyl]-2,3',4'-triol (17) 
MeMgCl (2.5 M solution in THF, 0.655 mmol, 1.1 equiv) was added to a solution of 3,4-
dimethoxyphenol (92.0 mg, 0.597 mmol, 1.0 equiv) in 5 mL THF at 0 °C under N2. 30 
minutes later, the solution was slowly transferred to a solution of 3-methoxy-o-benzoquinone 
(13) (96.0 mg, 0.696 mmol, 1.2 equiv) in 15 mL THF at –40 °C and stirred at that
temperature for 30 minutes at which time water and saturated NH4Cl solution was added. The 
mixture was extracted with Et2O, and the organic layers were washed with brine, dried with 
MgSO4 and concentrated under reduced pressure. Purification was achieved using GPC 
(Sephadex LH-20, MeOH 100%) affording the title compound as a dark red foam (39.7 mg, 
0.136 mmol, 23%). Rf (2:1 Et2O/pet.) = 0.10. IR: ν (cm
-1
) = 3407 (br), 2939 (w), 1508 (s),
1203 (s). 
1
H NMR (400 MHz, (CD3)2CO): δ 7.49 (br, 2 H, 3’-OH & 4’-OH), 6.83 (s, 1 H)),
6.70 (d, J = 1.7 Hz, 1 H), 6.68 (d, J = 1.7 Hz, 1 H), 6.58 (s, 1 H), 3.83 (s, 3 H), 3.78 (s, 3 H), 
3.77 (s, 3 H). 
13
C NMR (100 MHz, (CD3)2CO): δ 150.4, 148.9 (2-C), 148.7 (5’-C), 146.0 (3’-
C), 143.9, 133.7 (4’-C), 130.3, 120.8, 116.1 (6-C), 110.8, 105.7, 102.6 (3-C), 57.2 (5’-C), 
56.5, 56.2. ESI-MS: 291 (100, [M–H]
– 
 C15H15O6). HRESI-MS: Found m/z of 291.0866.
(calculated for C15H15O6 [M–H]
–
 291.0869).
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SYNTHESES OF STARTING MATERIALS 
Bromobenzo[d][1,3]dioxol-5-ol (7b) 
n-BuLi (1.4 M in hexanes, 5.45 mmol, 1.1 equiv) was added to a solution of MOM ether 18
(902 mg, 4.97 mmol, 1.0 equiv) in 12 mL THF at 0 °C under N2. 30 minutes later, bromine 
(872 mg, 5.45 mmol, 1.1 equiv) was added dropwise and stirred for a further 10 minutes at 
which time water was added. The mixture was extracted with Et2O, washed with brine, dried 
with MgSO4 and concentrated under reduced pressure. The crude material was subjected to 
flash column chromatography on silica using Et2O/pet = 1:1 as the eluent affording bromide 
19 with minor impurities which were not be removed, which was directly utilized in the 
subsequent step. TMSCl (1.56 g, 14.4 mmol) was added to a suspension of NaI (2.16 g, 14.4 
mmol) in 8.6 mL CH2Cl2 at 0 °C under N2. Five minutes later, a solution of MOM aryl 
bromide 19 in 5 mL CH2Cl2 was added dropwise and the mixture was stirred for one hour at 
which time water was added. The mixture was extracted with CH2Cl2, washed with brine, 
dried with MgSO4 and concentrated in vacuo. The crude was purified via flash column 
chromatography on silica using an eluent system of Et2O/pet = 1:1 followed by another silica 
gel column using acetone/pet = 1:2 as the eluent, affording the title compound as a beige 
waxy solid (232 mg, 1.08 mmol, 22%). Rf (2:1 Et2O/pet.) = 0.50. IR: ν (cm
-1
) = 3224 (br),
1460 (s), 1229 (m), 1046 (s), 934 (s). 
1
H NMR (400 MHz, CDCl3): δ 6.67 (d, J = 8.4 Hz, 1 H,
7-H), 6.48 (d, J = 8.4 Hz, 1 H, 6-H), 6.00 (s, 2 H, 2-H), 5.08 (s, 1 H, 5-OH). 
13
C NMR (100
MHz, CDCl3): δ 147.5 (5-C), 146.1 (3a-C), 141.4 (1a-C), 107.6 (7-C), 106.8 (6-C), 101.8 (2-
C), 91.5 (4-C). EI-MS: 218 (98, [M+2]
+•
 C7H5
81
BrO3), 216 (100, [M]
+•
 C7H5
79
BrO3). HREI-
MS: Found m/z of 217.9403 (calculated for C7H5
81
BrO3 [M+2]
+•
 217.9402), 215.9424
(calculated for C7H5
79
BrO3 [M]
+•
 215.9422).
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Compounds 20 and 21 were prepared in a similar manner to bromide 19. 
4-Benzyl-5-(methoxymethoxy)benzo[d][1,3]dioxole (20)
Colorless viscous oil (1.27 g, 4.67 mmol, 75%) from MOM ether 18 (1.13 g, 6.21 mmol, 1.0 
equiv), n-BuLi (1.4 M in hexanes, 6.83 mmol, 1.1 equiv) and benzyl bromide (1.59 g, 9.32 
mmol, 1.5 equiv). Rf (1:4 Et2O/pet.) = 0.42. IR: ν (cm
-1
) = 2898 (w), 1460 (s), 1453 (s), 1241
(m), 1152 (m), 1050 (s), 1036 (s). 
1
H NMR (400 MHz, CDCl3): δ 7.28-7.21 (m, 4 H), 7.15
(m, 1 H), 6.61 (d, J = 8.5 Hz, 1 H, 7-H), 6.52 (d, J = 8.5 Hz, 1 H, 6-H), 5.92 (s, 2 H, 2-H), 
5.05 (s, 2 H, 5-OCH2OCH3), 3.96 (s, 2 H, 4-CH2C6H5), 3.37 (s, 3 H, 5-OCH2OCH3). 
13
C
NMR (100 MHz, CDCl3): δ 150.5 (5-C), 146.6 (3a-C), 142.0 (1a-C), 140.3 (1’-C), 128.5, 
128.2, 125.9, 113.7 (4-C), 106.5, 105.7, 101.1 (2-C), 95.3 (5-OCH2OCH3), 56.0 (5-
OCH2OCH3), 29.8 (4-CH2C6H5). EI-MS: 272 (100, [M]
+•
 C16H16O4), 240 (96). HREI-MS:
Found m/z of 272.1050 (calculated for C16H16O4 [M]
+•
 272.1049).
5-(Methoxymethoxy)-4-(3-methylbut-2-en-1-yl)benzo[d][1,3]dioxole (21) 
Colorless viscous oil (598 mg, 2.39 mmol, 72%) from MOM ether 18 (608 mg, 3.34 mmol, 
1.0 equiv), n-BuLi (1.4 M in hexanes, 4.01 mmol, 1.2 equiv) and 3,3-dimethylallyl bromide 
(697 mg, 4.68 mmol, 1.3 equiv). Rf (1:6 Et2O/pet.) = 0.38. IR: ν (cm
-1
) = 2901 (w), 1460 (m),
1242 (m), 1153 (m), 1056 (s). 
1
H NMR (400 MHz, CDCl3): δ 6.57 (d, J = 8.4 Hz, 1 H, 7-H),
6.51 (d, J = 8.4 Hz, 1 H, 6-H), 5.91 (s, 2 H, 2-H), 5.25 (m, 1 H, 2’-H), 5.10 (s, 2 H, 5-
OCH2OCH3), 3.48 (s, 3 H, 5-OCH2OCH3), 3.30 (d, J = 7.2 Hz, 2 H, 1’-H), 1.74 (m, 3 H), 
1.68 (m, 3 H). 
13
C NMR (100 MHz, CDCl3): δ 150.5 (5-C), 146.2 (3a-C), 142.1 (1a-C), 132.1
(3’-C), 121.6 (2’-C), 114.5 (4-C), 106.8 (6-C), 105.1 (7-C), 101.0 (2-C), 95.5 (5-
OCH2OCH3), 56.0 (5-OCH2OCH3), 25.7 (3’-CH3 (trans)), 23.2 (1’-C), 17.7 (3’-CH3 (cis)). 
EI-MS: 250 (50, [M]
+•
 C14H18O4), 203 (100). HREI-MS: Found m/z of 250.1203 (calculated
for C14H18O4 [M]
+•
 250.1205).
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4-Benzylbenzo[d][1,3]dioxol-5-ol (7c)
23 mL of 3 M HCl(aq) solution was added to a solution of compound 20 (1.27 g, 4.67 mmol) 
in 70 mL MeOH and heated to 50 °C for one hour at which time water was added and 
extracted with Et2O. The organic layers were washed with brine, dried with MgSO4 and 
concentrated under reduced pressure. Purification was achieved using flash column 
chromatography on silica using Et2O/pet = 1:1 as the eluent affording the title compound as a 
colorless waxy solid (736 mg, 3.23 mmol, 69%). Rf (1:1 Et2O/pet.) = 0.37. IR: ν (cm
-1
) =
3492 (br), 1459 (s), 1453 (s), 1232 (m), 1051 (s). 
1
H NMR (400 MHz, CDCl3): δ 7.29-7.26
(m, 4 H), 7.21-7.18 (m, 1 H), 6.56 (d, J = 8.3 Hz, 1 H, 7-H), 6.24 (d, J = 8.3 Hz, 1 H, 6-H), 
5.93 (s, 2 H, 2-H), 4.45 (s, 1 H, 5-OH), 3.97 (s, 2 H, 4-CH2C6H5). 
13
C NMR (100 MHz,
CDCl3): δ 149.0 (5-C), 146.8 (3a-C), 141.2 (1a-C), 139.4 (1’-C), 128.6, 128.4, 126.3, 111.1 
(4-C), 107.0, 106.1, 101.1, 29.8 (4-CH2C6H5). EI-MS: 228 (86, [M]
+•
 C14H12O3), 150 (100).
HREI-MS: Found m/z of 228.0787 (calculated for C14H12O3 [M]
+•
 228.0786).
In a similar manner the following compound was prepared. 
4-(3-Methylbut-2-en-1-yl)benzo[d][1,3]dioxol-5-ol (7d) 
Colorless waxy solid (367 mg, 1.78 mmol, 75%) from compound 21 (598 mg, 2.39 mmol), 
0.24 mL of conc. HCl in 6 mL MeOH and stirred at room temperature for six hours. Rf (1:1 
Et2O/pet.) = 0.41. IR: ν (cm
-1
) = 3466 (br), 1458 (s), 1238 (m), 1055 (s). 
1
H NMR (400 MHz,
CDCl3): δ 6.54 (d, J = 8.3 Hz, 1 H, 7-H), 6.26 (d, J = 8.3 Hz, 1 H, 6-H), 5.90 (m, 2 H, 2-H), 
5.29 (m, 1 H, 2’-H), 4.89 (br, 1 H, 5-OH), 3.33 (d, J = 7.1 Hz, 2 H, 1’-H), 1.79 (s, 3 H), 1.75 
(s, 3 H). 
13
C NMR (100 MHz, CDCl3): δ 149.7 (5-C), 146.1 (3a-C), 140.9 (1a-C), 135.0 (3’-
C), 120.8 (2’-C), 110.8 (4-C), 107.0 (6-C), 105.8 (7-C), 100.9 (2-C), 25.7 (3’-CH3 (trans)), 
23.3 (1’-C), 17.8 (3’-CH3 (cis)). EI-MS: 206 (69, [M]
+•
 C12H14O3), 150 (100). HREI-MS:
Found m/z of 206.0940 (calculated for C12H14O3 [M]
+•
 206.0943).
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2,4'-Dimethoxy-[1,1'-biphenyl]-4-ol (7f) 
To a degassed solution of 4-bromo-3-methoxyphenol (285 mg, 1.42 mmol, 1.0 equiv) and 4-
methoxyphenylboronic acid pinacol ester (498 mg, 2.13 mmol, 1.5 equiv) in 5 mL of n-
propanol was added Pd(OAc)2 (31.8 mg, 0.142 mmol, 0.1 equiv) and PPh3 (112 mg, 0.426 
mmol, 0.3 equiv) followed by 2.1 mL of 2 M Na2CO3 solution and the mixture was heated to 
60 °C. 22 hours later, the flask was cooled to room temperature, diluted with water and 
extracted with Et2O. The organic layers were washed with brine, dried with MgSO4 and 
concentrated under reduced pressure. Purification was achieved using flash column 
chromatography on silica using Et2O/pet. = 1:1 as the eluent followed by trituration affording 
the title compound as a beige waxy solid (153 mg, 0.665 mmol, 47%). Rf (1:1 Et2O/pet.) = 
0.24. IR: ν (cm
-1
) = 3393 (br), 1608 (m), 1496 (s), 1465 (m), 1241 (s), 1196 (m), 1178 (m), 
1034 (m). 
1
H NMR (400 MHz, CDCl3): δ 7.43 (m, 2 H, 2’-H), 7.15 (d, J = 8.2 Hz, 1 H, 6-H), 
6.96 (m, 2 H, 3’-H), 6.51 (d, J = 2.2 Hz, 1 H, 3-H), 6.48 (dd, J = 2.2, 8.2 Hz, 1 H, 5-H), 5.31 
(br, 1 H, 4-OH), 3.85 (s, 3 H, 4’-OCH3), 3.77 (s, 3 H, 2-OCH3). 
13
C NMR (100 MHz, 
CDCl3): δ 158.2 (4’-C), 157.5 (2-C), 155.9 (4-C), 131.2 (6-C), 130.8 (1’-C), 130.4 (2’-C), 
123.1 (1-C), 113.5 (3’-C), 107.2 (5-C), 99.4 (3-C), 55.5 (2-OCH3), 55.3 (4’-OCH3). EI-MS: 
230 (100, [M]
+•
 C14H14O3), 213 (50). HREI-MS: Found m/z of 230.0942 (calculated for 
C14H14O3 [M]
+•
 230.0943). 
 
In a similar manner, the following compounds were prepared. 
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4-(4-Methoxyphenyl)naphthalen-1-ol (7n) 
Beige waxy solid (286 mg, 1.14 mmol, 57%) from 4-bromonaphthalen-1-ol (440 mg, 1.99 
mmol, 1.0 equiv), 4-methoxyphenylboronic acid pinacol ester (698 mg, 2.99 mmol, 1.5 
equiv), Pd(OAc)2 (22.3 mg, 0.0995 mmol, 0.05 equiv), PPh3 (78.3 mg, 0.299 mmol, 0.15 
equiv) and 2.9 mL of 2 M Na2CO3 solution in 7 mL of n-propanol. Stirred at 65 °C for four 
hours. Purified via flash column chromatography on silica using a gradient elution of 
Et2O/pet = 2:3 to 1:1. Rf (2:1 Et2O/pet.) = 0.60. IR: ν (cm
-1
) = 3379 (m), 1585 (m), 1514 (s), 
1243 (s), 1177 (m), 1022 (m). 
1
H NMR (400 MHz, CDCl3): δ 8.25 (d, J = 8.2 Hz, 1 H), 7.88 
(d, J = 7.9 Hz, 1 H), 7.50 (m, 1 H), 7.45 (m, 1 H), 7.38 (m, 2 H, 2’-H), 7.24 (d, J = 7.6 Hz, 1 
H, 3-H), 7.02 (m, 2 H, 3’-H), 6.86 (d, J = 7.6 Hz, 1 H, 2-H), 5.25 (br, 1 H, 1-OH), 3.89 (s, 3 
H, 4’-OCH3). 
13
C NMR (100 MHz, CDCl3): δ 158.7 (4’-C), 150.7 (1-C), 133.2 (1’-C), 
132.93, 132.91, 131.2 (2’-C), 126.7 (3-C), 126.4, 125.1, 124.4, 121.8, 113.7 (3’-C), 108.2 (2-
C), 55.4 (4’-OCH3). EI-MS: 250 (100, [M]
+•
 C17H14O2), 178 (25). HREI-MS: Found m/z of 
250.0996 (calculated for C17H14O2 [M]
+•
 250.0994). 
 
 
4-(3-Fluoro-4-methoxyphenyl)naphthalen-1-ol (7o) 
Beige waxy solid (323 mg, 1.21 mmol, 61%) from 4-bromonaphthalen-1-ol (440 mg, 1.99 
mmol, 1.0 equiv), 3-fluoro-4-methoxyphenylboronic acid pinacol ester (753 mg, 2.99 mmol, 
1.5 equiv). Stirred at 65 °C for four hours. Purified via flash column chromatography on 
silica using a gradient elution of Et2O/pet. = 2:3 to 1:1. Rf (1:1 Et2O/pet.) = 0.24. IR: ν (cm
-1
) 
= 3413 (br), 1587 (m), 1515 (s), 1306 (m), 1266 (s), 1229 (m), 1131 (m), 1023 (m). 
1
H NMR 
(400 MHz, CDCl3): δ 8.27 (dd, J = 7.8, 1.3 Hz, 1 H, 8-H), 7.88 (dd, J = 7.8, 0.8 Hz, 1 H, 5-
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H), 7.54-7.45 (m, 2 H, 6-H & 7-H), 7.24-7.17(m, 3 H, 2’-H & 6’-H & 3-H), 7.07 (dd, J = 8.6, 
8.4 Hz, 1 H, 5’-H), 6.86 (d, J = 7.7 Hz, 1 H, 2-H), 5.45 (br, 1 H, 1-OH), 3.98 (s, 3 H, 4’-
OCH3). 
13
C NMR (100 MHz, CDCl3): δ 152.1 (d, J = 244 Hz, 3’-C), 151.0 (1-C), 146.6 (d, J 
= 11 Hz, 4’-C), 133.9 (d, J = 7 Hz, 1’-C), 132.6 (4a-C), 131.7 (d, J = 1 Hz, 4-C), 126.9, 
126.7, 125.9 (d, J = 4 Hz, 6’-C), 125.7 (5-C), 125.2, 124.4 (8a-C), 121.9 (8-C), 117.9 (d, J = 
18 Hz, 2’-C), 113.3 (d, J = 3 Hz, 5’-C), 108.1 (2-C), 56.4 (4’-OCH3). EI-MS: 268 (100, [M]
+•
 
C17H13FO2), 251 (90). HREI-MS: Found m/z of 268.0902 (calculated for C17H13FO2 [M]
+•
 
268.0900). 
 
4-(Furan-2-yl)naphthalen-1-ol (7p) 
Yellow waxy solid (94.1 mg, 0.448 mmol, 52%) from 4-bromonaphthalen-1-ol (192 mg, 
0.863 mmol, 1.0 equiv), 2-furanylboronic acid pinacol ester (268 mg, 1.38 mmol, 1.6 equiv), 
Pd(OAc)2 (9.70 mg, 0.0432 mmol, 0.05 equiv), PPh3 (33.9 mg, 0.130 mmol, 0.15 equiv) and 
1.3 mL of 2 M Na2CO3 solution in 5 mL of n-propanol. Stirred at 50 °C for 12 hours. Purified 
via flash column chromatography on silica using Et2O/pet. = 2:3 as the eluent. Rf (2:1 
Et2O/pet.) = 0.58. IR: ν (cm
-1
) = 3350 (br), 1586 (s), 1515 (m), 1342 (m), 1260 (m), 1049 (s), 
1024 (m). 
1
H NMR (400 MHz, CDCl3): δ 9.34 (br, 1 H, 1-OH), 8.34 (d, J = 8.1 Hz, 1 H, 8-
H), 8.30 (d, J = 8.0 Hz, 1 H, 5-H), 7.71 (m, 1 H, 5’-H), 7.58-7.50 (m, 3 H, 3-H & 6-H & 7-
H), 6.99 (d, J = 7.9 Hz, 2-H), 6.66 (d, J = 3.3 Hz, 3’-H), 6.62 (dd, J = 3.3, 1.8 Hz, 1 H, 4’-H). 
13
C NMR (100 MHz, CDCl3): δ 154.8 (2’-C), 154.5 (1-C), 142.9 (5’-C), 132.7 (4a-C), 128.0, 
127.8, 126.0 (two resonances), 125.7, 123.4, 121.3 (8a-C), 112.1 (4’-C), 108.7, 108.6. EI-
MS: 210 (100, [M]
+•
 C14H10O2), 181 (90). HREI-MS: Found m/z of 210.0678 (calculated for 
C14H10O2 [M]
+•
 210.0681). 
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6-(3,4-Dimethoxyphenyl)naphthalen-2-ol (7r) 
Colorless solid (189 mg, 0.675 mmol, 50%) from 6-bromo-2-naphthol (300 mg, 1.36 mmol, 
1.0 equiv), 3,4-dimethoxyphenylboronic acid pinacol ester (538 mg, 2.04 mmol, 1.5 equiv), 
Pd(OAc)2 (15.3 mg, 0.0690 mmol, 0.05 equiv), PPh3 (54.2 mg, 0.207 mmol, 0.15 equiv), 2.0 
mL of 2 M Na2CO3 solution in 7 mL of n-propanol. Stirred at 50 °C for 14 hours. Purified 
using flash column chromatography on silica using Et2O/pet = 3:2 as the eluent, followed by 
trituration using petroleum spirits and CH2Cl2. Rf (2:1 Et2O/pet.) = 0.26. IR: ν (cm
-1
) = 3420 
(br), 1517 (s), 1505 (s), 1249 (s), 1220 (m), 1195 (m), 1141 (m), 1023 (m). 
1
H NMR (400 
MHz, CDCl3): δ 7.92 (br s, 1 H, 5-H), 7.80 (d, J = 8.8 Hz, 1 H, 4-H), 7.74 (d, J = 8.6 Hz, 1 H, 
8-H), 7.67 (dd, J = 8.6, 1.1 Hz, 1 H, 7-H), 7.24 (dd, J = 8.3, 1.6 Hz, 1 H, 6’-H), 7.21 (d, J = 
1.6 Hz, 1 H, 2’-H), 7.17 (d, J = 2.4 Hz, 1 H, 1-H), 7.13 (dd, J = 8.8, 2.4 Hz, 1 H, 3-H), 6.99 
(d, J = 8.1 Hz, 1 H, 5’-H), 3.85 (s, 3 H), 3.77 (s, 3 H). 
13
C NMR (100 MHz, CDCl3): δ 153.3 
(2-C), 149.3, 148.6, 136.3 (6-C), 134.2 (1’-C), 130.0 (4-C), 129.2, 126.8 (8-C), 126.2 (7-C), 
125.1 (5-C), 119.5 (6’-C), 118.2 (3-C), 111.6 (5’-C), 110.6 (2’-C), 109.3 (1-C), 56.03, 56.01. 
EI-MS: 280 (100, [M]
+•
 C18H16O3), 165 (20). HREI-MS: Found m/z of 280.1099 (calculated 
for C18H16O3 [M]
+•
 280.1099). 
 
 
3-Chloro-4-methoxyphenol (7j) 
This compound was prepared based on a modified literature procedure.
8
 3-Chloro-4-
methoxyphenylboronic acid pinacol ester (160 mg, 0.597 mmol, 1.0 equiv) was dissolved in 
10 mL of EtOH:H2O (v/v) = 2:1 and m-CPBA (103 mg, 0.597 mmol, 1.0 equiv) was added 
and stirred at room temperature for 3.5 hours. Saturated Na2S2O3 solution and saturated 
NaHCO3 solution were added, and the mixture was extracted with Et2O, washed with brine, 
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dried with MgSO4 and concentrated in vacuo. The residue was pushed through a plug of 
silica using Et2O/pet. = 1:1 as the eluent and the filtrates were concentrated under reduced 
pressure to afford the title compound as a colorless solid (80.0 mg, 0.506 mmol, 85%). 
Spectral characteristics complement literature data.
9
 
O
O
O
O
O
O
OH
m-CPBA, NaHCO3, CH2Cl2, rt, 1 h, then
K2CO3, MeOH, rt, 30 min
O
70%
7k
 
3,4,5-Trimethoxyphenol (7k) 
A suspension of 3,4,5-trimethoxybenzaldehyde (300 mg, 1.53 mmol, 1.0 equiv) and 630 mg 
NaHCO3 in 15 mL CH2Cl2 was treated with m-CPBA (503 mg, 2.91 mmol, 1.9 equiv) and 
the mixture was stirred at room temperature for one hour at which time saturated Na2S3O3 
solution was added and extracted with CH2Cl2. The organic layers were washed with 
saturated NaHCO3 solution, dried with MgSO4 and concentrated under reduced pressure. The 
residue was redissolved in 15 mL MeOH and 630 mg K2CO3 was added. The mixture was 
stirred at room temperature for 30 minutes at which time the solvent was removed, diluted 
with saturated NH4Cl solution and extracted with Et2O. The organic phases were washed with 
brine, dried with MgSO4 and concentrated in vacuo. Flash column chromatography on silica 
of the crude material afforded the title compound as a colorless solid (197 mg, 1.07 mmol, 
70%). Spectral characteristics complement literature data.
10
 
 
3-Methoxynaphthalen-1-ol. (7l) 
1,3-Dihydroxynaphthalene (800 mg, 5.00 mmol, 1.0 equiv.) was dissolved in 120 mL MeOH 
at room temperature. 2 M HCl methanolic solution was slowly added to the mixture and 
MgSO4 was added until a suspension persisted. The reaction was stirred for 14 days at which 
time the solvent was removed in vacuo, and Et2O and water were added. The aqueous layer 
was neutralized with NaHCO3. The combined organic layers were washed with brine, dried 
with MgSO4 and concentrated under reduced pressure. The crude material was purified via 
flash column chromatography on silica using Et2O/pet. = 1:1 as the eluent, affording the title 
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compound as a beige waxy solid. (558 mg, 3.21 mmol, 64%). Spectral characteristics 
complement previously reported literature.
11
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Chapter Three – Total Synthesis of 
Boletopsin 11 Enabled by Directed ortho-
C(sp2)-H Arylation  
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Introduction 
The first synthesis of polyoxygenated p-terphenyl dibenzofuran natural products was 
reported in 2009 by Takahashi and co-workers in the synthesis of vialinin B (9),51 a potent 
inhibitor of TNF-α production (Figure 6). Isolated from the fungus Thelephora vialis, vialinin 
B (9) contains a heavily oxygenated p-terphenyl dibenzofuran core that is further decorated 
with two phenylacetoxy groups. The main synthetic challenges presented include the 
construction of the dibenzofuran carbon skeleton and the selective acylation of the C-1-OH 
and C-2-OH groups. In 2014, Beekman and Barrow published the syntheses of structurally 
analogous natural products boletopsins 7 (53), 11 (1) and 12 (2) utilizing a similar approach 
(Figure 6).52 
 
Figure 6. Structures of vialinin B (9) and boletopsins 7 (53), 11 (1) and 12 (2) 
Takahashi’s synthetic approach to vialinin B (9) is depicted in Scheme 16. The p-terphenyl 
framework was assembled through iterative Suzuki-Miyaura cross coupling reactions and the 
heterocyclic B-ring was formed through a Cu2O-mediated Ullmann coupling reaction. This 
route was plagued by the instability of the intermediary compounds, predominantly caused 
by the electron-rich C-ring that readily underwent unproductive oxidation to the o-quinone. 
Multiple protecting group interconversion (PGI) operations were necessary to circumvent 
unproductive side reactions. Notably, the replacement of the MOM protecting group on C-
6 of terphenyl 54 with an electron-withdrawing benzyloxycarbonyl group was found to be 
crucial in order to successfully remove the methylenedioxy group from compound 55—
requiring two steps using lead(IV) acetate. Furthermore, this synthetic route required exotic 
cross-coupling partners that were not commercially available (e.g. chloroboronic acid 56), 
thus hindering scalability and throughput. 
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Scheme 16. Takahashi’s Synthetic Approach to Vialinin B (9) 
 
Acknowledging the drawbacks of the vialinin B synthesis as well as the limitations of our 
first generation boletopsin synthesis, we devised an alternative synthetic plan to p-terphenyl 
dibenzofuran natural products that was driven by innovative and state-of-the-art 
methodology. The following manuscript, published in the Journal of Organic Chemistry, outlines 
a nine-step synthesis of the fungal metabolite boletopsin 11. As illustrated in Scheme 17, our 
synthetic route features an oxidation-oxa-Michael cascade to rapidly assemble the 
dibenzofuran core, exploiting fundamental concepts discussed in Chapter Two. This key 
reaction is then followed by a directed ortho-C(sp2)-H arylation that completes the entire 
carbon framework, utilizing methodology that was recently published by Yu and co-
workers.53  
Scheme 17. Overview of Our Improved Synthesis of Boletopsin 11 (1) 
 
Although deceptively simple, meticulous synthetic planning was crucial for the preparation 
of boletopsin 11 due to the densely functionalized C-ring that was prone to oxidative 
degradation, as reported by Takahashi.51 Our improved synthesis of boletopsin 11 centered 
89 
 
 
 
on the strategic placement of the C-4 formyl functionality which acted as both a stabilizing 
group for the electron-rich dibenzofuran core and provided a synthetic handle to effect the 
directed ortho-C(sp2)-H arylation to append the D-ring. Overall, this strategy enabled a 
streamlined synthesis of boletopsin 11 using cheap and readily available feedstock chemicals.  
Additional studies into the scope of the palladium catalyzed ortho-C(sp2)-H functionalization 
demonstrated the versatility of this transformation, as well as the discovery of an 
unprecedented tandem C-H arylation reaction to efficiently access helical triaryl frameworks. 
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ABSTRACT: A nine-step synthesis of boletopsin 11 (1), a bioactive fungal natural product, is disclosed. Key features include a
one-pot [O]-oxa-Michael cascade to establish the polyoxygenated dibenzofuran core followed by a Pd-catalyzed directed ortho-
C(sp2)−H arylation to complete the fully functionalized carbon skeleton. Exploration of the latter transformation led to the
discovery of an unexpected tandem ortho-C(sp2)−H arylation event, and the scope of the directed ortho-C(sp2)−H reaction was
further investigated with coupling partners varying in stereoelectronic properties.
Boletopsins 1−14, isolated from the Boletopsis sp. ofmushrooms, are a family of natural products containing
a p-terphenyl carbon skeleton and a highly functionalized 3-
phenyldibenzofuran core.1 A signiﬁcant proportion of the
boletopsin family exhibit antibiotic properties,2 and several
boletopsins are identiﬁed as active ingredients in the fungi
utilized in Papua New Guinean medicine possessing in vitro
activity against a panel of human pathogenic bacteria.1b
Given their medicinal properties and their intriguing
structures, the boletopsins (and related natural products)2,3
have attracted ongoing interest from synthetic chemists
(Scheme 1).4 The highly oxygenated nature of the boletopsins
and their fully substituted aromatic C ring renders their
synthesis a challenge. Several dibenzofuran p-terphenyl natural
products have been prepared previously by our group5 and that
of Takahashi,6 including the syntheses of boletopsins 7, 11 (1),
12 (2), and vialinin B (3), which were completed in either 13
or 14 steps. The p-terphenyl carbon scaﬀolds were constructed
via sequential Suzuki−Miyaura cross-coupling reactions, and
the dibenzofuran core was forged through Baeyer−Villiger
oxidation and intramolecular Ullmann coupling. Both synthetic
routes required the use of unstable intermediates, and boronic
acid cross-coupling partners that were not commercially
available, which hindered material throughput.
As part of our ongoing interest in the development of new
methods for the preparation of dibenzofuran natural products,
we sought to formulate a new modular approach to the
boletopsin scaﬀold that was more eﬃcient and would mitigate
undesired decomposition pathways, which primarily stem from
the oxidation prone, electron-rich C ring. Herein we disclose a
successful realization of this goal that culminated in a nine-step
synthesis of boletopsin 11 (1). Our plan centered on the
strategic replacement of the C-4 methoxy group with a formyl
group that we anticipated would slow undesired oxidative
decomposition of the central C ring and serve as an enabling
group for the direct attachment of the D ring via a Pd-catalyzed
directed ortho-C(sp2)−H arylation, inspired by recent pub-
lications from the Yu laboratory7 and others.8 In this fashion,
the D ring of the boletopsin carbon framework was
disconnected from the rest of the molecule to reveal
benzaldehyde 4.
Based on related studies published from within our group,9
we anticipated benzaldehyde 4 could be disconnected back to
catechol 5 via an [O]-oxa-Michael transform.10 We presumed
catechol 5 would be easily accessible through Suzuki−Miyaura
cross-coupling of known bromide 6 and commercially available
3,4-dimethoxyphenyl boronic acid followed by chemoselective
demethylation.
Our synthesis of boletopsin 11 began with the preparation of
aryl bromide 6 in two steps from sesamol.5,11 Suzuki−Miyaura
cross-coupling4c of aryl bromide 6 with commercially available
3,4-dimethoxyphenyl boronic acid using catalytic Pd(OAc)2
and triphenylphosphine furnished biphenyl 7 in 89% yield
(Scheme 2). The selective cleavage of the methyl ethers of 7, in
preference over the methylenedioxy moiety, was successfully
realized with boron tribromide in DCM. Initial subjection of
catechol 5 to sodium periodate in a biphasic DCM/water
reaction medium12 resulted in a successful [O]-oxa-Michael
reaction; however, the isolated yield was poor due to the
instability of the dibenzofuran catechol product 8. This
problem was ultimately circumvented by switching the oxidant
to iodobenzene diacetate and using a mixed solvent system of
DCM/MeOH, followed by in situ protection of the catechol
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functionality. Thus, upon completion of the [O]-oxa-Michael
process, the byproducts including the solvent could be easily
removed under vacuum and the intermediary dibenzofuran
catechol subjected to dimethylation conditions using methyl
iodide and potassium carbonate, delivering benzaldehyde 4 in
two steps from biphenyl 7.
With benzaldehyde 4 in hand, the stage was set to complete
the boletopsin carbon skeleton and install the D ring via
directed ortho-C(sp2)−H arylation. We were delighted to ﬁnd
that subjection of benzaldehyde 4 and p-iodoanisole to the
protocol developed by Yu and co-workers,7a using amino acid 9
as the transient directing group (DG), led to the isolation of the
desired product 10 in 51% yield, along with 26% of recovered
benzaldehyde 4. Attempts to push the reaction to completion
using a higher catalyst loading, prolonged reaction time, or
additional equivalents of silver triﬂuoroacetate proved un-
successful and resulted in diminished overall yield.13 It was
surmised that this process was hampered by the steric
encumbrance of both the transient DG 9 and the heavily
substituted benzaldehyde 4, impeding formation of the
intermediary ﬁve-membered palladacycle and subsequent
reaction with p-iodoanisole. To the best of our knowledge,
this is the ﬁrst example of a 2,3,4,5-tetrasubstituted
benzaldehyde engaging in a Pd-catalyzed directed ortho-
C(sp2)−H arylation. Furthermore, during our attempts to
optimize this transformation by employing a large excess of p-
iodoanisole, a secondary directed C(sp2)−H arylation event
was discovered on the newly appended p-methoxyphenyl ring,
leading to triaryl 11 in 3% yield. Presumably formed through
the transient seven-membered palladacycle,8g this tandem Pd-
catalyzed directed ortho-C(sp2)−H arylation sequence is
currently under further investigation in our laboratory and
could have great potential for the rapid synthesis of exotic
helical triaryls.14
At this stage, our attention turned to the removal of the
methylenedioxy moiety of 10 and acetylation of the resulting
catechol functionality. Previous syntheses of the boletopsins
and related structures were compelled to undertake multiple
concession steps at this point to realize this goal. Anticipating
that the aldehyde functionality at C-5 would stabilize the
electron-rich catechol C ring upon deprotection, treatment of
10 with phosphorus pentachloride followed by hydrolysis
successfully cleaved the methylenedioxy group, and although
the intermediary catechol was isolable, we found it convenient
to simply acetylate the crude reaction mixture with acetic
anhydride and triethylamine, which furnished diacetate 12 in
83% yield over two steps from 10.
To complete the total synthesis of boletopsin 11, diacetate
12 was submitted to Baeyer−Villiger oxidation with m-CPBA
and sodium bicarbonate. Subsequent in situ formate hydrolysis
followed by treatment with excess potassium carbonate and
methyl iodide successfully eﬀected methylation to deliver
boletopsin 11 (1), in a single-pot operation.
We were particularly intrigued by the versatility of the Pd-
catalyzed ortho-C(sp2)−H arylation reaction that enabled the
direct functionalization of a sterically encumbered benzalde-
hyde 4. In eﬀorts to further evaluate the breadth of this
transformation, a brief substrate screen was conducted with aryl
iodides diﬀering in electronics and substitution patterns to
examine the eﬀects of electronic and steric properties of the aryl
iodide on the reaction outcome.
As shown in Scheme 3, the directed ortho-C(sp2)−H
arylation was performed on ﬁve additional examples. Both
electron-rich and -deﬁcient ortho-substituted aryl iodides
performed poorly, presumably owing to steric eﬀects (13 and
14), while reaction with 4-iodotoluene and 3-bromoiodoben-
zene exhibited modest reactivity (15 and 16).15 The best result
was obtained with 4-iodobenzoate, aﬀording the adduct 17 in
72% isolated yield.
In summary, the total synthesis of boletopsin 11 (1) has been
completed in nine steps from sesamol. In comparison to the
previous route (13 steps),5 our synthesis is not only shorter but
also more robust, employing bench stable synthetic inter-
mediates and commercially available cross-coupling partners
that provide a more scalable route to the natural product. The
pivotal steps include a one-pot [O]-oxa-Michael addition
reaction to forge the dibenzofuran scaﬀold, followed by a
sterically challenging directed ortho-C(sp2)−H arylation
reaction that appends the D ring to complete the carbon
framework. The latter, to the best of our knowledge, is the ﬁrst
application of this methodology in natural product synthesis.16
The key feature of our synthetic plan was the strategic
placement of the C-5 formyl group on the C ring, which served
as a stabilizing group as well as the synthetic handle to enact the
directed ortho-C(sp2)−H arylation. During the course of this
study, a secondary ortho-C(sp2)−H arylation reaction was
discovered, with the isolation of triaryl 11. Further explorations
into this tandem directed ortho-C(sp2)−H arylation reaction
focusing on induction of axial chirality employing chiral
directing groups8c,17 are currently ongoing in our laboratory.
Scheme 1. p-Terphenyl Natural Products and Retrosynthetic
Analysis
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■ EXPERIMENTAL SECTION
General Experimental Methods. NMR spectra were recorded at
298 K, 400 MHz for 1H, 100 MHz for 13C, on an Avance 400
instrument. Chemical shifts are reported in ppm (δ). NMR
experiments were run in CDCl3 or (CD3)2CO as indicated.
1H
NMR spectra are referenced to the resonance from residual CHCl3 at
7.26 ppm and CHD2COCD3 at 2.05 ppm.
13C NMR spectra are
referenced to the central peak in the signal from CDCl3 at 77.0 ppm
and (CD3)2CO at 29.8 ppm. The multiplicities of
1H NMR resonances
are expressed by abbreviations: br (broad), s (singlet), d (doublet), t
(triplet), quartet (q), m (multiplet), and combinations thereof for
highly coupled systems. 13C NMR spectra were run as proton
decoupled experiments. EI-MS were recorded on an Agilent HP 6890
series gas GC/MS with a 7683 series injector. HREI-MS data were
recorded on a Waters AutoSpec Premier spectrometer magnetic sector
instrument, operating at 70 eV. ESI-MS data were recorded on a ZMD
Micromass spectrometer with a Waters Alliance 2690 HPLC. HRESI-
MS were recorded on a Waters LCT Premier time-of-ﬂight (TOF)
mass spectrometer and a Thermo Fisher Scientiﬁc Velos Pro Orbitrap
mass spectrometer. Mass spectra are displayed as mass/charge ratios
(m/z) and relative abundance (% of base peak intensity). Thin layer
chromatography (TLC) was run on Merck silica gel 60 F254 aluminum
backed plates, and details of the eluents are described in each
procedure. Plates were observed under UV light (254 nm) and/or
developed in a ceric phosphomolybdic acid dip followed by heating.
Flash column chromatography was run on silica gel (230−400 mesh)
using the eluent system detailed for each procedure. Anhydrous
solvents were obtained from commercial sources unless otherwise
noted. The petroleum ether (pet.) fraction used was 60−80 °C unless
otherwise stated. IR spectra were recorded on the Alpha Bruker Optics
FT-IR spectrometer or the PerkinElmer Spectrum Two FT-IR
spectrometer (neat), and all data were reported in wavenumbers.
Peak intensities are described by s (strong), m (medium), w (weak),
and br (broad). 6-Hydroxybenzo[d][1,3]dioxole-5-carbaldehyde5 and
7-bromo-6-hydroxybenzo[d][1,3]dioxole-5-carbaldehyde (6)11 were
prepared according to literature procedures.
7-(3,4-Dimethoxyphenyl)-6-hydroxybenzo[d][1,3]dioxole-5-car-
baldehyde (7). In a two-neck ﬂask ﬁtted with a condenser, aryl
bromide 6 (1.00 g, 4.08 mmol, 1.0 equiv), 3,4-dimethoxyphenyl
boronic acid (1.49 g, 8.19 mmol, 2.0 equiv), Pd(OAc)2 (64 mg, 0.285
mmol, 7 mol %), and triphenylphosphine (225 mg, 0.859 mmol, 21
mol %) were degassed and reﬁlled with nitrogen. A 30 mL aliquot of
solvent (THF/n-propanol = 1:1, degassed by bubbling nitrogen) was
added to the solids and stirred for 10 min at which time 6 mL of
degassed 2 M Na2CO3 solution were added and the reaction was
heated to 80 °C in an oil bath for 17 h. The mixture was cooled to
room temperature and diluted with EtOAc and brine. The mixture was
extracted with EtOAc, washed with brine, dried with MgSO4, and
concentrated under reduced pressure. The crude material was
subjected to ﬂash column chromatography on silica, using a gradient
elution of EtOAc/pet. = 1:3 to 1:2 to aﬀord the title compound as a
yellow solid (1.10 g, 3.63 mmol, 89%). Rf (1:2 EtOAc/pet.) = 0.26.
1H
NMR (400 MHz, CDCl3) δ 12.3 (s, 1H), 9.68 (s, 1H), 7.20 (d, J = 2.0
Hz, 1H), 7.18 (m, 1H), 6.96 (d, J = 8.0 Hz, 1H), 6.86 (s, 1H), 6.04 (s,
2H), 3.92 (s, 3H), 3.91 (s, 3H); 13C NMR (100 MHz, CDCl3) δ
194.1, 158.7, 152.4, 148.9, 148.6, 141.0, 122.6, 122.4, 113.8, 113.3,
112.5, 110.9, 108.2, 102.0, 56.0, 55.9. IR: ν (cm−1) = 1626 (m), 1520
(m), 1256 (s), 1227 (s) 1025 (s). MS (EI) m/z 302 (100, [M]+•
C16H14O6). HRMS (EI) m/z: [M]
+• calcd for C16H14O6 302.0790;
found 302.0788.
7-(3,4-Dihydroxyphenyl)-6-hydroxybenzo[d][1,3]dioxole-5-car-
baldehyde (5). Boron tribromide (1.0 M solution in DCM, 8.34
mmol, 2.1 equiv) was added dropwise to a solution of biphenyl 7 (1.20
g, 3.97 mmol, 1.0 equiv) in 45 mL of anhydrous DCM at 0 °C under
nitrogen. The solution was slowly warmed to room temperature and
stirred for 1.5 h at which time it was poured into ice water. The
mixture was extracted exhaustively with EtOAc, and the combined
organic layers were washed with brine, dried with MgSO4 and
concentrated under reduced pressure. The residue was puriﬁed via
ﬂash column chromatography on silica using EtOAc/pet. = 3:2 as the
Scheme 2. Total Synthesis of Boletopsin 11 (1)
aIsolated yield (rsm (recovered starting material) yield of 4). bYield was determined by 1H NMR spectroscopy using dibromomethane as the
internal standard. The NMR yield of the tandem ortho-C(sp2)−H product 11 could be improved to 10% with reaction conditions: Pd(OAc)2 (10
mol %), DG 9 (40 mol %), AgTFA (2 equiv), ClCH2CO2H (10 equiv), p-iodoanisole (7 equiv), HFIP (0.2 M), 110 °C, 36 h.
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eluent, aﬀording the title compound as a yellow solid (889 mg, 3.24
mmol, 82%). Rf (2:1 EtOAc/pet.) = 0.48.
1H NMR (400 MHz,
(CD3)2CO) δ 12.4 (br s, 1H), 9.76 (s, 1H), 7.97 (br s, 2H), 7.15 (d, J
= 2.0 Hz, 1H), 7.10 (s, 1H), 7.01 (dd, J = 8.2, 2.0 Hz, 1H), 6.88 (d, J =
8.2 Hz, 1H), 6.11 (s, 2H); 13C NMR (100 MHz, (CD3)2CO) δ 196.1,
159.4, 153.5, 145.9, 145.4, 142.1, 123.0, 122.8, 118.2, 115.6, 114.8,
113.3, 109.0, 103.1. IR: ν (cm−1) = 3486 (m), 3283 (br), 1608 (s),
1409 (s), 1307 (s), 1249 (s), 1039 (s). MS (EI) m/z 274 (100, [M]+•
C14H10O6). HRMS (EI) m/z: [M]
+• calcd for C14H10O6 274.0477;
found 274.0476.
8,9-Dimethoxybenzo[b][1,3]dioxolo[4,5-e]benzofuran-5-carbal-
dehyde (4). Biphenyl catechol 5 (274 mg, 1.00 mmol, 1.0 equiv) was
dissolved in 58 mL of solvent (DCM/MeOH = 7:1) at 0 °C under
nitrogen. PhI(OAc)2 (451 mg, 1.40 mmol, 1.4 equiv) was added to the
solution in one portion and stirred for 1 h at which time an additional
0.2 equiv of PhI(OAc)2 was added. After 0.5 h, the solvent was
removed in vacuo and the residue was redissolved in 10 mL of DMF.
Potassium carbonate (1.38 g, 10.0 mmol, 10 equiv) was added to the
solution followed by methyl iodide (1.14 g, 8.00 mmol, 8.0 equiv), and
the mixture was stirred at room temperature under nitrogen for 17 h,
at which time the reaction was diluted with water and EtOAc. The
reaction mixture was extracted with EtOAc, and the combined organic
layers were washed with brine, dried with MgSO4, and concentrated
under reduced pressure. Puriﬁcation was achieved using ﬂash column
chromatography on silica using DCM/pet/EtOAc = 8:2:1 as the
eluent aﬀording the title compound as a colorless solid (135 mg, 0.451
mmol, 45%). Rf (1:1 EtOAc/pet.) = 0.32.
1H NMR (400 MHz,
CDCl3) δ 10.40 (s, 1H), 7.31 (s, 1H), 7.30 (s, 1H), 7.15 (s, 1H), 6.22
(s, 2H), 3.99, (s, 3H), 3.98 (s, 3H); 13C NMR (100 MHz, CDCl3) δ
186.1, 155.9, 151.8, 150.4, 146.7, 145.3, 143.8, 114.2, 111.7, 109.9,
103.4, 103.3, 102.9, 95.7, 56.6, 56.3. IR: ν (cm−1) = 1671 (m), 1503
(m), 1396 (m), 1261 (s), 1112 (s). MS (EI) m/z 300 (100, [M]+•
C16H12O6). HRMS (EI) m/z: [M]
+• calcd for C16H12O6 300.0634;
found 300.0633.
8,9-Dimethoxy-4-(4-methoxyphenyl)benzo[b][1,3]dioxolo[4,5-e]-
benzofuran-5-carbaldehyde (10). In a sealed tube, benzaldehyde 4
(137 mg, 0.457 mmol, 1.0 equiv), p-iodoanisole (214 mg, 0.914 mmol,
2.0 equiv), Pd(OAc)2 (10.3 mg, 0.0457 mmol, 10 mol %), DG 9 (18.8
mg, 0.183 mmol, 40 mol %), AgTFA (202 mg, 0.914 mmol, 2.0 equiv),
and ClCH2CO2H (432 mg, 4.57 mmol, 10 equiv) were suspended in
2.3 mL of HFIP, and the mixture was stirred for 10 min and then
heated to 100 °C in an oil bath covered in aluminum foil to minimize
exposure to light. After 22 h, the reaction was cooled to room
temperature and 3.00 g of sodium bicarbonate were added. The
suspension was stirred vigorously for 10 min and then ﬁltered through
Celite using EtOAc, and the ﬁltrates were concentrated in vacuo.
Puriﬁcation was achieved via ﬂash column chromatography on silica
using DCM/pet/EtOAc = 8:2:1 as the eluent aﬀording the title
compound as a brown amorphous solid (94 mg, 0.246 mmol, 51%
isolated yield, 26% recovered starting material). Rf (1:1 EtOAc/pet.) =
0.30. 1H NMR (400 MHz, CDCl3) δ 9.96 (s, 1H), 7.43−7.41 (m, 2H),
7.34 (s, 1H), 7.29 (s, 1H), 7.04−7.02 (m, 2H), 6.23 (s, 2H), 4.00 (s,
3H), 3.98 (s, 3H), 3.88 (s, 3H); 13C NMR (100 MHz, CDCl3) δ
188.7, 159.8, 153.8, 152.2, 150.3, 146.7, 143.8, 140.9, 132.2, 123.8,
123.6, 113.9, 112.9, 111.5, 109.3, 103.1, 102.7, 96.1, 56.6, 56.3, 55.4.
IR: ν (cm−1) = 2926 (w), 1683 (m), 1597 (m), 1475 (m), 1249 (s),
1199 (s), 1174 (s), 1124 (s). MS (ESI) m/z 445 (55, [M + K]+
C23H18O7K), 429 (100, [M + Na]
+ C23H18O7Na), 407 (20, [M + H]
+
C23H19O7). HRMS (ESI) m/z: [M + Na]
+ calcd for C23H18O7Na
429.0950; found 429.0951.
4-(4′,5-Dimethoxy-[1,1′-biphenyl]-2-yl)-8,9-dimethoxybenzo[b]-
[1,3]dioxolo[4,5-e]benzofuran-5-carbaldehyde (11). In a sealed tube,
benzaldehyde 4 (35 mg, 0.12 mmol, 1.0 equiv), p-iodoanisole (192
mg, 0.819 mmol, 7.0 equiv), Pd(OAc)2 (2.6 mg, 0.012 mmol, 10 mol
%), DG 9 (4.8 mg, 0.047 mmol, 40 mol %), AgTFA (51.7 mg, 0.234
mmol, 2.0 equiv), and ClCH2CO2H (111 mg, 1.17 mmol, 10 equiv)
were suspended in 0.6 mL of HFIP, and the mixture was stirred for 10
min and then heated to 110 °C in an oil bath covered in aluminum foil
to minimize exposure to light. After 36 h, the reaction was cooled to
room temperature and 300 mg of sodium bicarbonate were added.
The suspension was stirred vigorously for 10 min, then ﬁltered
through Celite, and concentrated in vacuo. The NMR yields were
determined using dibromomethane as the internal standard. The NMR
yields of benzaldehydes 4, 10, and 11 were 10%, 41%, and 10%,
respectively. Separation of 10 and 11 proved to be diﬃcult due to the
highly similar Rf values, and a pure sample for characterization could
be obtained via ﬂash column chromatography using a gradient eluent
system (pet/EtOAc = 5:1 to 4:1). Rf (1:4 EtOAc/pet.) = 0.06.
1H
NMR (400 MHz, CDCl3) δ 9.92 (s, 1H), 7.35 (d, J = 8.5 Hz, 1H),
7.29 (s, 1H), 7.25 (s, 1H), 7.09−7.07 (m, 2H), 7.02−6.98 (m, 2H),
6.70−6.68 (m, 2H), 6.12 (d, J = 1.1 Hz, 1H), 5.80 (d, J = 1.1 Hz, 1H),
3.97 (s, 3H), 3.96 (s, 3H), 3.90 (s, 3H), 3.71 (s, 3H); 13C NMR (100
MHz, CDCl3) δ 188.4, 160.0, 158.7, 153.9, 152.1, 150.3, 146.7, 143.74,
143.65, 141.2, 133.1, 132.9, 130.1, 123.4, 122.4, 115.5, 113.4, 113.0,
112.6, 111.5, 109.3, 103.1, 102.5, 96.2, 56.6, 56.3, 55.4, 55.1. IR: ν
(cm−1) = 2930 (w), 1685 (m), 1603 (m), 1494 (m), 1475 (m), 1309
(m), 1248 (m), 1200 (s), 1175 (s), 1127 (s). MS (ESI) m/z 551 (20,
[M + K]+ C30H24O8K), 535 (100, [M + Na]
+ C30H24O8Na), 513 (30,
[M + H]+ C30H25O8). HRMS (ESI) m/z: [M + H]
+ calcd for
C30H25O8 513.1544; found 513.1538.
4-Formyl-7,8-dimethoxy-3-(4-methoxyphenyl)dibenzo[b,d]furan-
1,2-diyl Diacetate (12). Compound 10 (46.7 mg, 0.115 mmol, 1.0
equiv) was suspended in 1.0 mL of toluene, and phosphorus
pentachloride (79.8 mg, 0.384 mmol, 3.3 equiv) was added. The
mixture was then heated to 60 °C in an oil bath under nitrogen. After
2 h, the temperature was increased to 80 °C and 0.8 mL of 1 M
HCl(aq) solution was added and stirred for 0.5 h at which time 2 mL
of sat. NaHCO3(aq) solution and 2 mL of EtOH were added and
heated to 90 °C for 1.5 h. The mixture was cooled to room
temperature, acidiﬁed with 1 M HCl(aq) solution, and extracted with
Scheme 3. Scope of the Directed ortho-C(sp2)−H Arylation
Reaction with Benzaldehyde 4a
aReaction conditions: benzaldehyde 4 (0.110 mmol, 1 equiv), aryl
iodide (3 equiv), Pd(OAc)2 (10 mol %), DG 9 (40 mol %),
ClCH2CO2H (10 equiv), AgTFA (2 equiv), HFIP (0.6 mL), 110 °C,
20 h. Isolated yields (rsm yields). bReaction conditions: benzaldehyde
4 (0.457 mmol, 1 equiv), p-iodoanisole (2 equiv), Pd(OAc)2 (10 mol
%), DG 9 (40 mol %), ClCH2CO2H (10 equiv), AgTFA (2 equiv),
HFIP (2.3 mL), 100 °C, 22 h. Isolated yields (rsm yields).
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EtOAc. The organic layers were washed with brine, dried with MgSO4,
and concentrated under reduced pressure to aﬀord the crude which
was immediately subjected to the next step. The crude material was
dissolved in 1.5 mL of DCM under nitrogen at 0 °C, and acetic
anhydride (32.8 mg, 0.322 mmol, 2.8 equiv) was added slowly.
Subsequently, triethylamine (116 mg, 1.15 mmol, 10 equiv) was added
dropwise and the reaction was stirred at room temperature for 15 min
at which time sat. NH4Cl(aq) solution was added and extracted with
EtOAc. The organic layer was washed with brine, dried with MgSO4,
and concentrated under reduced pressure. The crude material was
subjected to ﬂash column chromatography on silica using a gradient
elution of EtOAc/pet. = 3:2 to 1:1, aﬀording the title compound as a
pale yellow paste (45.7 mg, 0.0956 mmol, 83% over two steps). Rf (1:1
EtOAc/pet.) = 0.23. 1H NMR (400 MHz, CDCl3) δ 9.88 (s, 1H), 7.32
(s, 1H), 7.30−7.28 (m, 2H), 7.17 (s, 1H), 7.00−6.98 (m, 2H), 3.99 (s,
3H), 3.97 (s, 3H), 3.88 (s, 3H), 2.51 (s, 3H), 2.03 (s, 3H). 13C NMR
(100 MHz, CDCl3) δ 189.3, 168.5, 167.0, 159.9, 153.2, 152.6, 151.1,
146.9, 140.1, 136.9, 136.2, 132.0, 124.2, 120.0, 118.4, 113.7, 112.2,
103.2, 96.2, 56.6, 56.3, 55.4, 20.5, 20.1. IR: ν (cm−1) = 2937 (w), 1779
(m), 1477 (m), 1201 (s), 1171 (s), 1124 (s). MS (ESI) m/z 501 (100,
[M + Na]+ C26H22O9Na). HRMS (ESI) m/z: [M + Na]
+ calcd for
C26H22O9Na 501.1162; found 501.1167.
Boletopsin 11 (1). Dibenzofuran 12 (56.6 mg, 0.118 mmol, 1.0
equiv) was dissolved in 1.7 mL of DCM, and sodium bicarbonate
(49.7 mg, 0.592 mmol, 5.0 equiv) was added followed by m-CPBA
(40.8 mg, 0.236 mmol, 2.0 equiv). The mixture was stirred under
nitrogen at room temperature for 18 h at which time potassium
carbonate (65.2 mg, 0.472 mmol, 4.0 equiv) and 1.5 mL of EtOH and
0.4 mL of water were added and stirred at room temperature for 6 h.
The solvent was removed in vacuo, and the residue was redissolved in
4 mL of acetone, which was subsequently treated with potassium
carbonate (130 mg, 0.944 mmol, 8.0 equiv) and methyl iodide (134
mg, 0.944 mmol, 8.0 equiv); the suspension was stirred under nitrogen
at room temperature for 17 h. The mixture was ﬁltered through a small
plug of silica (DCM/pet/EtOAc = 8:2:1 as the eluent), and the ﬁltrate
was concentrated under reduced pressure. The crude was puriﬁed by
ﬂash column chromatography on silica using DCM/pet/EtOAc =
8:2:1 as the eluent, aﬀording boletopsin 11 (1) as a colorless solid
(26.0 mg, 0.0542 mmol, 46%). Spectral data match the previously
reported data of the isolated natural product.1b Rf (8:2:1 DCM/pet./
EtOAc) = 0.48. 1H NMR (400 MHz, CDCl3) δ 7.32−7.30 (m, 2H),
7.15−7.14 (m, 2H), 6.97−6.95 (m, 2H), 3.99 (s, 3H), 3.963 (s, 3H),
3.956 (s, 3H), 3.86 (s, 3H), 2.47 (s, 3H), 2.02 (s, 3H); 13C NMR (100
MHz, CDCl3) δ 168.7, 168.0, 159.0, 151.6, 151.0, 146.4, 145.9, 140.7,
136.0, 131.5, 131.1, 125.4, 124.9, 119.3, 113.8, 113.5, 103.5, 95.7, 61.0,
56.5, 56.3, 55.2, 20.5, 20.2. 1H NMR (400 MHz, (CD3)2CO) δ 7.37 (s,
1H), 7.28 (s, 1H), 7.28−7.26 (m, 2H), 7.03−7.00 (m, 2H), 3.97 (s,
3H), 3.95 (s, 3H), 3.93 (s, 3H), 3.85 (s, 3H), 2.49 (s, 3H), 2.01 (s,
3H); 13C NMR (100 MHz, (CD3)2CO) δ 168.9, 168.7, 160.2, 152.5,
152.2, 148.0, 146.6, 141.3, 137.4, 132.5, 132.3, 126.5, 125.9, 120.2,
114.3, 114.2, 104.7, 96.9, 61.3, 56.8, 56.6, 55.5, 20.4, 20.2. IR: ν (cm−1)
= 2937 (w), 1773 (m), 1478 (m), 1280 (m), 1208 (s), 1189 (s), 1172
(s). MS (ESI) m/z 519 (50, [M + K]+ C26H24O9K), 503 (100, [M +
Na]+ C26H24O9Na), 481 (10, [M + H]
+ C26H25O9). HRMS (ESI) m/
z: [M + Na]+ calcd for C26H24O9Na 503.1318; found 503.1321.
General Procedure for the Synthesis of Compounds 13−
17.7a In a sealed tube, benzaldehyde 4 (33.0 mg, 0.110 mmol, 1.0
equiv), aryl iodide (0.330 mmol, 3.0 equiv), Pd(OAc)2 (2.5 mg, 0.011
mmol, 10 mol %), DG 9 (4.5 mg, 0.044 mmol, 40 mol %),
ClCH2CO2H (104 mg, 1.10 mmol, 10 equiv), and AgTFA (48.6 mg,
0.220 mmol, 2.0 equiv) were dissolved in 0.6 mL of HFIP and the
mixture was stirred at room temperature for 10 min. The tube was
then sealed and heated to 110 °C in an oil bath for 20 h covered in
aluminum foil. The mixture was then cooled to room temperature, and
300 mg of sodium bicarbonate were added. The suspension was
vigorously stirred for 10 min and ﬁltered through Celite using EtOAc
as the eluent. The ﬁltrate was concentrated and subjected to ﬂash
column chromatography to aﬀord the various p-terphenyl products.
Methyl 2-(5-Formyl-8,9-dimethoxybenzo[b][1,3]dioxolo[4,5-e]-
benzofuran-4- yl)benzoate (13). Compound 13 was obtained from
benzaldehyde 4 following the general procedure, using 2-iodobenzoate
as the aryl iodide. Flash column chromatography on silica using
DCM/pet./EtOAc = 8:2:1 aﬀorded compound 13 (2.0 mg, 0.0046
mmol, 4%) along with recovered benzaldehyde 4 (26.2 mg, 0.0873
mmol, 79%). Rf (8:2:1 DCM/pet./EtOAc) = 0.30.
1H NMR (400
MHz, CDCl3) δ 9.99 (s, 1H), 8.13 (dd, J = 7.7, 1.1 Hz, 1H), 7.65−
7.61 (m, 2H), 7.56−7.52 (m, 2H), 7.38 (dd, J = 7.0, 1.0 Hz, 1H), 7.36
(s, 1H), 7.27 (s, 1H), 6.17 (s, 2H), 4.00 (s, 3H), 3.99 (s, 3H), 3.70 (s,
3H); 13C NMR (100 MHz, CDCl3) δ 187.5, 166.7, 154.7, 152.2,
150.3, 146.7, 143.7, 140.9, 133.8, 132.3, 132.0, 130.7, 130.6, 128.7,
122.4, 112.7, 111.7, 109.5, 103.2, 102.8, 96.0, 56.6, 56.3, 52.1. IR: ν
(cm−1) = 2926 (w), 1725 (m), 1685 (m), 1606 (m), 1476 (m), 1310
(m), 1256 (m), 1200 (s), 1127 (s). MS (ESI) m/z 473 (45, [M + K]+
C24H18O8K), 457 (100, [M + Na]
+ C24H18O8Na), 435 (15, [M + H]
+
C24H19O8). HRMS (ESI) m/z: [M + H]
+ calcd for C24H19O8
435.1074; found 435.1074.
8,9-Dimethoxy-4-(2-methoxyphenyl)benzo[b][1,3]dioxolo[4,5-e]-
benzofuran-5-carbaldehyde (14). Compound 14 was obtained from
benzaldehyde 4 following the general procedure, using o-iodoanisole as
the aryl iodide. Flash column chromatography on silica using DCM/
pet./THF = 25:10:1 aﬀorded compound 14 (1.2 mg, 0.030 mmol, 3%)
along with recovered benzaldehyde 4 (23.9 mg, 0.0800 mmol, 72%). Rf
(25:10:1 DCM/pet./THF) = 0.23. 1H NMR (400 MHz, CDCl3) δ
9.83 (s, 1H), 7.48−7.43 (m, 1H), 7.39 (dd, J = 7.6, 1.9 Hz, 1H), 7.36
(s, 1H), 7.29 (s, 1H), 7.12−7.08 (m, 1H), 7.04−7.02 (m, 1H), 6.24 (d,
J = 1.1 Hz, 1H), 6.19 (d, J = 1.1 Hz, 1H), 4.00 (s, 3H), 3.98 (s, 3H),
3.78 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 188.9, 157.0, 153.6,
152.3, 150.3, 146.7, 144.1, 141.2, 132.0, 130.5, 120.7, 120.6, 119.8,
112.8, 111.6, 111.0, 109.6, 103.2, 102.7, 96.2, 56.6, 56.3, 55.6. IR: ν
(cm−1) = 2936 (w), 1687 (m), 1597 (m), 1476 (m), 1310 (m), 1245
(m), 1199 (s), 1127 (s). MS (ESI) m/z 445 (35, [M + K]+
C23H18O7K), 429 (100, [M + Na]
+ C23H18O7Na), 407 (20, [M +
H]+ C23H19O7). HRMS (ESI) m/z: [M + H]
+ calcd for C23H19O7
407.1125; found 407.1121.
8,9-Dimethoxy-4-(p-tolyl)benzo[b][1,3]dioxolo[4,5-e]benzofuran-
5-carbaldehyde (15). Compound 15 was obtained from benzaldehyde
4 following the general procedure, using 4-iodotoluene as the aryl
iodide. Flash column chromatography on silica using DCM/pet./THF
= 25:10:1 aﬀorded compound 15 (7.4 mg, 0.019 mmol, 17%) along
with recovered benzaldehyde 4 (10 mg, 0.033 mmol, 30%). Rf
(25:10:1 DCM/pet./THF) = 0.30. 1H NMR (400 MHz, CDCl3) δ
9.96 (s, 1H), 7.39−7.37 (m, 2H), 7.35 (s, 1H), 7.32−7.28 (m, 3H),
6.22 (s, 2H), 4.00 (s, 3H), 3.98 (s, 3H), 2.44 (s, 3H); 13C NMR (100
MHz, CDCl3) δ 188.7, 153.8, 152.3, 150.4, 146.7, 143.8, 140.9, 138.6,
130.8, 129.1, 128.7, 123.8, 112.9, 111.5, 109.4, 103.1, 102.8, 96.2, 56.6,
56.3, 21.3. IR: ν (cm−1) = 2923 (w), 1684 (m), 1597 (m), 1476 (m),
1309 (m), 1199 (s), 1176 (s), 1126 (s). MS (ESI) m/z 429 (65, [M +
K]+ C23H18O6K), 413 (100, [M + Na]
+ C23H18O6Na). HRMS (ESI)
m/z: [M + H]+ calcd for C23H19O6 391.1176; found 391.1169.
4-(3-Bromophenyl)-8,9-dimethoxybenzo[b][1,3]dioxolo[4,5-e]-
benzofuran-5-carbaldehyde (16). Compound 16 was obtained from
benzaldehyde 4 following the general procedure, using 3-bromoiodo-
benzene as the aryl iodide. Flash column chromatography on silica
using DCM/pet./THF = 25:10:1 aﬀorded compound 16 (11.8 mg,
0.0259 mmol, 24%) along with recovered benzaldehyde 4 (8.3 mg,
0.028 mmol, 25%). Rf (25:10:1 DCM/pet./THF) = 0.35.
1H NMR
(400 MHz, CDCl3) δ 10.00 (s, 1H), 7.67−7.66 (m, 1H), 7.59 (ddd, J
= 7.4, 1.8, 1.7 Hz, 1H), 7.42−7.33 (m, 3H), 7.29 (s, 1H), 6.24 (s, 2H),
4.00 (s, 3H), 3.99 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 187.8,
154.2, 152.4, 150.6, 146.8, 144.0, 141.0, 134.0, 133.5, 131.6, 129.8,
129.6, 122.5, 121.4, 112.5, 111.3, 109.9, 103.2, 103.0, 96.1, 56.6, 56.4.
IR: ν (cm−1) = 2927 (w), 1686 (m), 1606 (m), 1472 (m), 1310 (m),
1200 (s), 1127 (s). MS (ESI) m/z 479 (99, [M + 2 + Na]+
C22H15O6
81BrNa), 477 (100, [M + Na]+ C22H15O6
79BrNa). HRMS
(ESI) m/z: [M + 2 + H]+ calcd for C22H16O6
81Br 457.0104; found
457.0100.
Methyl 4-(5-Formyl-8,9-dimethoxybenzo[b][1,3]dioxolo[4,5-e]-
benzofuran-4-yl)benzoate (17). Compound 17 was obtained from
benzaldehyde 4 following the general procedure, using 4-iodobenzoate
as the aryl iodide. Flash column chromatography on silica using
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DCM/pet./EtOAc = 8:2:1 aﬀorded compound 17 (34.8 mg, 0.0802
mmol, 72%) along with recovered benzaldehyde 4 (4.8 mg, 0.016
mmol, 14%). Rf (8:2:1 DCM/pet./EtOAc) = 0.43.
1H NMR (400
MHz, CDCl3) δ 10.00 (s, 1H), 8.16 (m, 2H), 7.57 (m, 2H), 7.34 (s,
1H), 7.28 (s, 1H), 6.23 (s, 2H), 4.00 (s, 3H), 3.98 (s, 3H), 3.96 (s,
3H); 13C NMR (100 MHz, CDCl3) δ 187.7, 166.6, 154.3, 152.4,
150.6, 146.9, 144.0, 141.0, 136.8, 130.9, 130.1, 129.5, 121.8, 112.4,
111.3, 109.9, 103.2, 102.9, 96.1, 56.6, 56.3, 52.3. IR: ν (cm−1) = 2952
(w), 1720 (s), 1685 (m), 1608 (m), 1435 (m), 1310 (s), 1277 (s),
1201 (s), 1127 (s). MS (ESI) m/z 473 (25, [M + K]+ C24H18O8K),
457 (100, [M + Na]+ C24H18O8Na), 435 (20, [M + H]
+ C24H19O8).
HRMS (ESI) m/z: [M + Na]+ calcd for C24H18O8Na 457.0899; found
457.0895.
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Introduction 
The following manuscript published in Organic Letters outlines the first total synthesis of 
suillusin (28). The fungal metabolite was first isolated by Yoo and co-workers from Suillus 
granulatus in 2001,27 and is hypothesized to be a rearrangement product of polyporic acid. 
Suillusin is unique from a structural and biosynthetic standpoint, comprised of a densely 
functionalized 1H-cyclopenta[b]benzofuran core―an aberrant feature amongst other natural 
products derived from arylpyruvic acids―raising questions surrounding its biosynthetic 
origin (see Chapter One pages 6-9). 
To date, the total synthesis of suillusin is yet to be reported. Our synthetic approach towards 
suillusin employs a Michael-benzoin multicatalytic cascade54 to construct the entire molecular 
framework in a single-pot operation (Scheme 18).   
Scheme 18. Total Synthesis of Suillusin (28) 
 
After extensive evaluation of various late stage oxidation pathways, we developed a 
successful strategy that featured a Rubottom-Swern oxidation sequence of the central 
cyclopentanone core followed by a SmI2-mediated deoxygenation reaction to afford the 
methylated natural product precursor 57. The global deprotection of the methyl ether 
protecting groups was achieved using 10 equivalents of boron tribromide to afford the target 
natural product in 10 steps overall.  
The scalable racemic synthesis of suillusin enabled the separation of the racemic mixture of 
compound 57 using preparative chiral phase HPLC. Global deprotection of the enantiopure 
natural product precursors (+)-57 and (-)-57 allowed us to compare the specific rotation 
values of enantiopure suillusin (+)-28 and (-)-28 with the original isolation report, providing 
concrete evidence that suillusin was isolated as a racemate and reinforcing the enzyme-
116 
 
independent biosynthetic proposal previously summarized in the concluding sections of 
Chapter One.  
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ABSTRACT: The ﬁrst total synthesis of the fungal natural product suillusin is reported. The key features of the synthesis
include a Michael-benzoin multicatalytic cascade that assembles the entire carbon framework in a single step, and a Rubottom-
Swern oxidation sequence that yields the requisite diketone oxidation state of the core framework. This 10-step synthesis of
suillusin will allow further evaluation of the biogenesis and the biological activity of the fungal metabolite.
Suillusin (1) is a polyoxygenated fungal natural product ﬁrstisolated from the fruiting bodies of Suillus granulatus by
Yoo and co-workers in 2001 (Scheme 1).1 Structural
elucidation of the natural product was achieved using NMR
and mass spectrometry, suggesting the connectivity and the
relative stereochemistry of the densely substituted 1H-
cyclopenta[b]benzofuran. In the isolation report, it was
hypothesized that suillusin (1) biosynthetically originates
from polyporic acid, thus sharing a common metabolic
precursor with the p-terphenyl natural product family2 (e.g.,
ganbajunin 8 (2)3 and boletopsin 11 (3)4). Notably, fungal
metabolites that feature the densely functionalized 1H-
cyclopenta[b]benzofuran core are relatively atypical among
other members of the arylpyruvic acid p-terphenyl family,
raising questions surrounding suillusin’s biosynthetic origin.
The striking structural similarity between suillusin (1) and
the more recently isolated racemic natural product (±)-tylo-
pilusin B (4)5 led us to speculate that there is a close
biosynthetic relationship between the two natural products and
that suillusin (1) is formed through a predisposed extracellular
oxidative rearrangement6 rather than through enzymatic
manipulation.3 Moreover, the enantiopurity of suillusin (1)
was not disclosed in the isolation report. Our interest in
probing the biosynthetic origin in combination with the
fascinating molecular architecture of suillusin fueled our desire
to embark on a synthetic campaign toward this natural
product. Herein, we present the successful realization of our
endeavors through the ﬁrst total synthesis of suillusin (1).
Inspired by Frontier’s elegant total synthesis of rocaglamide
(5) (Scheme 2A),7 our initial synthetic eﬀorts toward suillusin
(1) centered on a Nazarov cyclization strategy to form the
diketone core. The rocaglamides8 belong to the ﬂavagline
family9 of natural products and exhibit a heavily decorated
cyclopenta[b]benzofuran tricyclic framework which has
attracted extensive interest from the synthetic community.10
Unfortunately, our attempts at applying the strategy were
plagued by the diﬃculty in preparing the appropriate Nazarov
cyclization precursor. Although a plethora of synthetic
maneuvers exist to prepare the heterocyclic framework of the
rocaglamides,7a,11 we viewed this shortcoming in the suillusin
synthesis as an opportunity to develop a more modular
approach to access this molecular scaﬀold.
In considering a more robust and eﬃcient synthetic strategy,
we drew inspiration from Rovis’ one-step multicatalytic
asymmetric synthesis of substituted cyclopentanone frame-
works, which proceeds through an organocatalytic Michael
addition followed by an intramolecular benzoin condensation
(Scheme 2B).12 We envisioned accessing the diketone core of
suillusin through an analogous process from the readily
available building blocks 6 and 7 (Scheme 2C). Mapping
this key ring disconnection onto the structural framework of
suillusin facilitates a concise retrosynthetic analysis. We
envisioned that suillusin (1) could be accessed through
deoxygenation of the C-8b alcohol functionality of precursor
8, which could be prepared by selective oxidation of C-2 of the
cyclopentanone framework of 9. The resulting cyclopentanone
9 could be generated utilizing Rovis’ multicatalytic Michael-
benzoin reaction cascade from readily available benzoic ester 6
and commercially available cinnamaldehyde 7.
Our synthetic work began with the Michael-benzoin
multicatalytic cascade to build the carbon skeleton of suillusin
from benzoic ester 613 and 3,4-dimethoxycinnamaldehyde 7
(Scheme 3). We were delighted to ﬁnd that applying the
conditions reported by Rovis and co-workers12 successfully
aﬀorded the formal (3 + 2) cycloaddition adduct 9 in 55%
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yield as an inconsequential mixture of diastereoisomers (1:1.7)
on gram scale. Interestingly, this sequence was found to
produce cyclopentanone 9 in racemic form, with no chiral
induction transposed from the enantiopure pyrrolidine catalyst
10. The erosion of ee could be attributed to the reversibility of
the initial Michael reaction catalyzed by the pyrrolidine catalyst
10, a phenomenon that was also encountered by Rovis.12 As
our primary focus was the completion of the total synthesis, we
prioritized investigation of the required redox manipulations of
the cyclopentanone core. Furthermore, the enantiopurity of
suillusin (1) was not stated in the isolation report (speciﬁc
rotation [α]D = +4 (c = 1.0, MeOH)). Given that the
biosynthetically related natural product (±)-tylopilusin B (4)
has been isolated in racemic form, we hoped to probe the
hypothesis that suillusin (1) is also a racemic natural product.
With a robust and scalable route to cyclopentanone 9, we
shifted our focus toward the oxidation chemistry at C-2. Our
initial eﬀorts revolved around SeO2-mediated Riley oxidation
conditions,14 all of which resulted in unproductive elimination
pathways15 to form the cyclopentenone congener (see
Supporting Information (SI) for details). Exposure of cyclo-
pentanone 9 to one-pot α-halogenation-Kornblum oxidation
conditions16 also yielded the undesired cyclopentenone. With
little success in accomplishing the direct oxidation of 9 to form
the diketone core, an alternative stepwise approach was
devised.
Our revised synthetic approach explored a Rubottom−
Swern oxidation sequence to introduce the diketone
functionality through an α-hydroxyketone intermediate. Treat-
ment of cyclopentanones 9a and 9b with 2.2 equiv of LDA
followed by the addition of TBSCl aﬀorded silyl enol ethers
11a and 11b in 67% yield. Epoxidation of 11a and 11b with m-
CPBA diastereoselectively delivered epoxides 12a and 12b,
where the stereochemical outcome was most likely dictated by
the preferential approach of m-CPBA to the less hindered face
of silyl enol ether 11.
Acidic hydrolysis of epoxides 12a and 12b in aqueous
hydrochloric acid and THF produced compounds 13, 14, and
15 in 73% yield with a molar ratio of 1.5:1.1:1. The hemiketal
silyl ether 15 was obtained as a relatively stable compound,17
and the crystallographic data indirectly conﬁrmed the relative
stereochemistry of α-hydroxyketones 13 and 14 (see SI for
details). As anticipated, oxidative treatment18 of the incon-
sequential mixture of alcohols 13, 14, and 15 followed by
TBAF deprotection delivered 16 in 95% yield as the sole
product, existing exclusively as the tautomeric 2-hydroxyenone
form. This tautomer fortuitously abolishes the stereochemistry
at C-3 which resolves the diastereomeric mixture.
To complete the synthesis of suillusin, the tertiary alcohol
functionality of compound 16 was reduced using SmI2 and t-
BuOH19 in 51% yield in a diastereoselective manner, with the
required stereocontrol as determined through X-ray crystallo-
Scheme 1. Arylpyruvic Acid Biosynthesis of p-Terphenyl
Natural Products and the Proposed Biogenesis of
(±)-Tylopilusin B (4) and Suillusin (1)
Scheme 2. Frontier’s Synthesis of Rocaglamide (5), Rovis’
Asymmetric Synthesis of Functionalized Cyclopentanones,
and Our Retrosynthetic Analysis of Suillusin (1)
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graphic analysis of the reduced compound 17. Finally, global
deprotection of the aryl ethers was achieved with 10 equiv of
boron tribromide in 63% yield, leaving the ester functionality
untouched. Spectroscopic data of synthetic suillusin (1) were
identical to those of the natural sample published by Yoo et al.,
conﬁrming the unique carbon skeleton of the natural product.1
Given our interest in the enantiopurity of the naturally
isolated suillusin (1), we sought to determine the speciﬁc
rotation of the synthesized enantiomers to compare against the
values reported by Yoo and co-workers.1 Initial eﬀorts to
separate the racemic mixture of suillusin (1) by chiral HPLC
were thwarted by the poor solubility of the natural product
rendering the separation a challenge. This was eventually
mitigated through eﬃcacious separation of the precursor 17
using chiral HPLC followed by global deprotection of the
enantiopure 17 to deliver both enantiomers of suillusin
(speciﬁc rotations [α]D = −822 (c = 1.0 MeOH), +749 (c =
1.0 MeOH) respectively), providing persuasive evidence that
the naturally isolated suillusin (1) is indeed racemic. The lower
magnitude of the positive enantiomer reﬂects a 91% optical
purity obtained from chiral HPLC.
To summarize, the ﬁrst total synthesis of suillusin (1) was
completed in 10 steps. The synthetic strategy involved a one-
pot Michael-benzoin multicatalytic cascade to rapidly construct
the entire carbon framework followed by late-stage redox
elaborations to procure the natural product. The crux of the
synthetic route showcases the powerful methodology designed
by Rovis12 and stands as a proof-of-principle for future
synthetic aspirations toward structurally related targets. The
conclusive speciﬁc rotation data of enantiopure suillusin
indicate that the natural product was isolated as a racemate,
oﬀering an enzyme-independent biosynthetic pathway for this
unique fungal metabolite. With a robust route to supply
suillusin (1) secured, current eﬀorts in our laboratory are
focusing on assessing the biological properties of these fungal
metabolites and completing the synthesis of unnatural
analogues.
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General Experimental 
NMR spectra were recorded at 298 K, 400 MHz for 1H, 100 MHz for 13C on an Avance 400 instrument. 
Chemical shifts are reported in ppm (δ). NMR experiments were run in CDCl3, (CD3)2CO or CD3OD as 
indicated, 1H NMR spectra are referenced to the resonance from residual CHCl3 at 7.26 ppm, 
CHD2COCD3 at 2.05 ppm and CHD2OD at 3.31 ppm. 13C NMR spectra are referenced to the central 
peak in the signal from CDCl3 at 77.0 ppm, (CD3)2CO at 29.8 ppm and CD3OD at 49.0 ppm. The 
multiplicities of 1H NMR resonances are expressed by abbreviations: br s (broad singlet), s (singlet), d 
(doublet), t (triplet), quartet (q), m (multiplet) and combinations thereof for highly coupled systems. 13C 
NMR spectra were run as proton decoupled experiments. 1H and 13C signals where appropriate are 
described by chemical shift δ (multiplicity, J (Hz), integration).  
ESI-MS were recorded on a ZMD Micromass spectrometer with Waters Alliance 2690 HPLC. HRESI-
MS were recorded on a Waters LCT Premier time of flight (TOF) mass spectrometer and a Thermo 
Fisher Scientific Velos Pro Orbitrap mass spectrometer. Mass spectra are displayed as mass/charge 
ratios (m/z) and relative abundance (% of base peak intensity).  
Thin layer chromatography (TLC) was run on Merck silica gel 60 F254 aluminum backed plates and 
details of the eluents are described in each procedure. Plates were observed under UV light (254 nm) 
and/or developed in ceric phosphomolybdic acid dip (1% aqueous solution) followed by heating. Flash 
column chromatography was run on silica gel (230-400 mesh) using the eluent system detailed for each 
procedure. According to standard procedures,1 all solvents were dried and distilled either immediately 
prior to use or stored as appropriate. Petroleum ether (expressed as abbreviation pet) employed in this 
work ranged from 60-80 °C boiling range.  
Analytical Chiral UPC was conducted using the Waters UPC2 (Supercritical Fluid Chromatography) 
system, Waters Trefoil CEL2 (2.5 µm, 3.0 mm × 150 mm) column and a photodiode array detector. 
Preparative Chiral HPLC was conducted using the Waters 600 HPLC controller, Kromasil 5-CelluCoat 
SFC CT8031 (21.2 mm × 250 mm) column, Waters 717plus autosampler and Waters 2996 photodiode 
array detector. 
Optical rotations were measured on a Rudolph Research Analytical Autopol I Automatic Polarimeter 
using a sodium lamp (589 nm) as the light source with a cell length of 100 mm. [α]D values are reported 
in units of 10-1degcm2g-1 at concentration (c) in g/100mL. 
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Proposed Mechanism for the Hydrolysis of Epoxides 12a and 12b 
126
S6 
 
Experimental Section 
Synthesis of Benzoic Ester 6 and Cinnamaldehyde 7 
 
Methyl 5-methoxy-2-(2-methoxy-2-oxoethoxy)benzoate was prepared according to previously published 
procedures.2 In an oven dried 500 mL three neck round bottom flask, t-BuOK (6.49 g, 57.9 mmol, 2.1 
equiv) was suspended in 200 mL of THF and cooled to 0 °C under nitrogen. A solution of Methyl 5-
methoxy-2-(2-methoxy-2-oxoethoxy)benzoate (7.00g, 27.6 mmol, 1.0 equiv) in 50 mL of THF was added 
dropwise and the flask was warmed to room temperature. The mixture was stirred for two hours at which 
time it was cooled to 0 °C and quenched with water and acidified with 1 M HCl solution. The reaction 
was extracted with EtOAc, washed with brine, dried with MgSO4 and concentrated under reduced 
pressure. The crude residue was triturated with pet/EtOAc = 4:1 then petroleum ether 100% to afford 
the desired product as a beige powder (5.32 g, 24.0 mmol, 87% yield). Spectral characteristics matched 
with previously published data.3 
 
In a 250 mL Erlenmeyer flask, 4-acetoxy-3-methoxy-trans-cinnamaldehyde (3.00 g, 13.6 mmol, 1.0 
equiv) was dissolved in 100 mL of MeOH. 50 mL of water and 50 mL of saturated NaHCO3 solution 
were added followed by 12 mL of 1 M aqueous NaOH solution. The dark brown mixture was stirred 
vigorously for 0.5 hours at which time it was acidified with 1 M HCl solution. The mixture was extracted 
with Et2O, washed with brine, dried with MgSO4 and concentrated under reduced pressure. The residue 
was dissolved in 20 mL of DMF under nitrogen at room temperature. K2CO3 (2.83 g, 20.5 mmol, 1.5 
equiv) was added followed by a dropwise addition of MeI (2.13 g, 15.0 mmol, 1.1 equiv) and the 
suspension was stirred for 1.5 hours at which time water was added and the mixture was extracted with 
Et2O. The organic layers were washed with brine, dried with MgSO4 and concentrated under reduced 
pressure. Purification was achieved using flash column chromatography on silica using a gradient eluent 
(pet/EtOAc = 3:2 to 1:1), affording 3,4-dimethoxy-trans-cinnamaldehyde (7) as an orange waxy solid 
(2.03 g, 10.6 mmol, 78% over two steps). Spectral data match with previously reported literature.4 
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Michael-Benzoin Multicatalytic Cascade 
Pyrrolidine catalyst 10 was prepared according to a literature procedure.5 In a 250 mL round bottom 
flask, benzoic ester 6 (1.55 g, 7.00 mmol, 1.2 equiv), 3,4-dimethoxy-trans-cinnamaldehyde (7) (1.12 g, 
5.83 mmol, 1.0 equiv) and triazolium salt (211 mg, 0.583 mmol, 10 mol %) were suspended in 25 mL of 
chloroform at room temperature. Pyrrolidine catalyst 10 (380 mg, 1.17 mmol, 20 mol %) was added to 
the reaction mixture followed by sodium acetate (144 mg, 1.75 mmol, 30 mol %). The orange suspension 
was stirred under nitrogen at room temperature for five hours at which time 1 M HCl solution was added 
and the mixture was extracted with DCM. The combined organic layers were washed with brine, dried 
with MgSO4 and concentrated in vacuo. Purification was achieved by flash column chromatography on 
silica using pet/EtOAc = 1:1 as the eluent, affording diasteromers 9a and 9b as yellow foams (molar 
ratio of 9a:9b = 1:1.7, 1.32 g, 3.19 mmol, 55% yield). The relative stereochemistry at C-3, C-3a and C-
8b of compounds 9a and 9b were unambiguously confirmed by X-ray crystallography (see S41-S42 for 
crystallographic data).  
Note: Separation of diastereoisomers 9a and 9b could be achieved using flash column chromatography 
on silica with a gradient eluent system (pet/EtOAc = 2:1 to 1:1). The synthetic sequence was carried out 
using the separated compounds 9a and 9b independently to obtain characterization data for subsequent 
compounds 11a, 11b, 13, 14, and 15. 
1H NMR (400 MHz, CDCl3) δ 7.08 (d, J = 8.9 Hz, 1 H), 6.99 (dd, J = 8.9, 2.7 Hz, 1 H), 6.94 (d, J = 2.7 
Hz, 1 H), 6.91 (d, J = 1.6 Hz, 1 H), 6.88-6.82 (m, 2 H), 3.91 (s, 3 H), 3.88 (s, 3 H), 3.78 (s, 3 H), 3.56 (s, 
3 H), 3.57 (dd, J = 13.2, 9.1 Hz, 1 H), 3.26 (dd, J = 19.1, 13.2 Hz, 1 H), 3.24 (br s, 1 H), 2.91 (dd, J = 
19.1, 9.0 Hz, 1 H). 
13C NMR (100 MHz, CDCl3) δ 209.3, 167.1, 155.8, 152.4, 148.9, 148.7, 128.4, 124.5, 119.8, 119.5, 
113.1, 111.1, 110.7, 108.8, 100.0, 89.0, 56.1, 56.0, 55.9, 52.5, 45.8, 40.3. 
LRMS (ESI+) m/z (%) = 437 (100, [M+Na]+, C22H22O8Na), 453 (20, [M+K]+, C22H22O8K). 
HRMS (ESI+) calculated for C22H22O823Na 437.1207, found 437.1211. 
Rf (0.15) pet/EtOAc = 1:1. 
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1H NMR (400 MHz, CDCl3) δ 6.88-6.79 (m, 5 H), 6.77-6.75 (m, 1 H), 4.34 (dd, J = 14.7, 7.3 Hz, 1 H), 
3.86 (s, 3 H), 3.85 (br s, 1 H), 3.82 (s, 3 H), 3.77 (s, 3 H), 3.74 (s, 3 H), 3.01 (dd, J = 16.3, 14.7 Hz, 1 
H), 2.69 (dd, J = 16.3, 7.3 Hz, 1 H). 
13C NMR (100 MHz, CDCl3) δ 208.6, 168.8, 155.4, 154.6, 148.7 (coincident resonances), 127.4, 124.7, 
120.9, 118.8, 111.8, 110.98, 110.95, 108.3, 96.4, 89.1, 56.0, 55.82, 55.80, 53.1, 45.6, 39.1.  
LRMS (ESI+) m/z (%) = 437 (100, [M+Na]+, C22H22O8Na). 
HRMS (ESI+) calculated for C22H22O823Na 437.1207, found 437.1209. 
Rf (0.17) pet/EtOAc = 1:1. 
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Preparation of Silyl Enol Ethers 11a and 11b 
In an oven dried 250 mL two neck round bottom flask, diisopropylamine (709 mg, 7.02 mmol, 2.2 equiv) 
was added to 20 mL of THF under nitrogen and the flask was cooled to -40 °C. n-BuLi (1.4 M in hexanes, 
6.70 mmol, 2.1 equiv) was added dropwise and stirred for 10 minutes at which time a solution of 
compounds 9a and 9b (1.32 g, 3.19 mmol, 1.0 equiv) in 16 mL of THF was added dropwise, followed 
by a slow addition of 12 mL of DMPU. The dark orange mixture was stirred for 20 minutes at which time 
a solution of TBSCl (1.16 g, 7.66 mmol, 2.4 equiv) in 5 mL of THF was added dropwise. The reaction 
was warmed to -10 °C over one hour and quenched with saturated NH4Cl solution. The mixture was 
extracted with Et2O, washed with brine, dried with MgSO4 and concentrated under reduced pressure. 
Purification was achieved with silica gel flash column chromatography using pet/EtOAc = 3:1 as the 
eluent, affording the diastereomeric TBS enol ethers 11a and 11b as an orange viscous oil (1.36 g, 2.13 
mmol, 67%). 
1H NMR (400 MHz, CDCl3) δ 7.04 (d, J = 8.8 Hz, 1 H), 7.01 (d, J = 2.7 Hz, 1 H), 6.90 (dd, J = 8.8, 2.7 
Hz, 1 H), 6.83-6.79 (m, 3 H), 4.89 (d, J = 1.9 Hz, 1 H), 3.89 (s, 3 H), 3.85 (s, 3 H), 3.78 (s, 3 H), 3.75 (d, 
J = 1.9 Hz, 1 H), 3.28 (s, 3 H), 1.07 (s, 9 H), 0.76 (s, 9 H), 0.35 (s, 3 H), 0.29 (s, 3 H), -0.06 (s, 3 H), -
0.39 (s, 3 H). 
13C NMR (100 MHz, CDCl3) δ 166.6, 154.6, 154.1, 151.7, 148.4, 148.0, 132.0, 128.3, 120.2, 117.1, 
112.4, 111.4, 110.6, 109.9, 103.8, 103.0, 90.1, 55.9, 55.8 (coincident resonances), 53.9, 51.3, 25.9, 
25.8, 18.4, 18.1, -2.5, -3.9, -4.49, -4.52. 
LRMS (ESI+) m/z (%) = 665 (100, [M+Na]+, C34H50O8Si2Na), 511 (30, [M-OTBS]+, C28H35O7Si). 
HRMS (ESI+) calculated for C34H50O8Si223Na 665.2942, found 665.2949. 
Rf (0.26) pet/EtOAc = 3:1. 
1H NMR (400 MHz, CDCl3) δ 6.90 (d, J = 2.7 Hz, 1 H), 6.77 (d, J = 8.2 Hz, 1 H), 6.72 (dd, J = 8.2, 1.8 
Hz, 1 H), 6.70 (dd, J = 8.7, 2.7 Hz, 1 H), 6.58 (d, J = 1.8 Hz, 1 H), 6.55 (d, J = 8.7 Hz, 1 H), 4.96 (d, J = 
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2.0 Hz, 1 H), 4.89 (d, J = 2.0 Hz, 1 H), 3.85 (s, 3 H), 3.76 (s, 3 H), 3.71 (s, 3 H), 3.69 (s, 3 H), 0.93 (s, 9 
H), 0.87 (s, 9 H), 0.21 (s, 3 H), 0.19 (s, 3 H), 0.13 (s, 3 H), 0.07 (s, 3 H). 
13C NMR (100 MHz, CDCl3) δ 169.5, 154.2, 154.1, 152.8, 148.3, 148.1, 130.8, 129.2, 121.4, 115.3, 
112.2, 110.6, 110.2, 110.1, 108.2, 97.6, 94.2, 55.9, 55.8, 55.5, 52.5, 50.2, 25.9, 25.8, 18.5, 18.3, -2.6, -
3.1, -4.6, -5.0. 
LRMS (ESI+) m/z (%) = 665 (25, [M+Na]+, C34H50O8Si2Na), 511 (100, [M-OTBS]+, C28H35O7Si). 
HRMS (ESI+) calculated for C34H50O8Si223Na 665.2942, found 665.2938. 
Rf (0.28) pet/EtOAc = 3:1. 
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Rubottom Oxidation of Silyl Enol Ethers 11a and 11b 
In a 250 mL round bottom flask, sodium bicarbonate (1.35 g, 16.1 mmol, 8.0 equiv) was added to a 
solution of TBS enol ethers 11a and 11b (1.29 g, 2.01 mmol, 1.0 equiv) in 25 mL of DCM at 0 °C. m-
CPBA (1.11 g, 6.43 mmol, 3.2 equiv) was added in one portion and the suspension was stirred at 0 °C 
for two hours at which time 25 mL of saturated NaHCO3 solution and 25 mL of saturated Na2S2O3 
solution were added and the mixture was vigorously stirred for 10 minutes. The mixture was extracted 
with Et2O and the combined organic layers were washed with saturated NaHCO3 solution. The ethereal 
solution was dried with MgSO4 and concentrated under reduced pressure to afford a diastereomeric 
mixture of epoxides 12a and 12b as a beige foam (1.61 mmol, 80% yield determined by 1H NMR 
spectroscopy using dibromomethane as an internal standard), and was subjected to the next step 
immediately. 
In a 250 mL round bottom flask, epoxides 12a and 12b (1.61 mmol) were dissolved in 10 mL of THF 
and 10 mL of 1 M HCl solution was added followed by 60 µL of conc. HCl (36%). The reaction was 
stirred at room temperature for 12 hours at which time it was extracted with DCM, washed with brine, 
dried with MgSO4 and concentrated under reduced pressure. The crude material was purified with flash 
column chromatography using pet/EtOAc = 3:2 as the eluent, affording compounds 13, 14 and 15 as a 
mixture with a molar ratio of 1.5:1.1:1 (total 1.18 mmol, 73% combined yield determined by 1H NMR 
spectroscopy using dibromomethane as an internal standard). 
1H NMR (400 MHz, CDCl3) δ 7.15-7.13 (m, 1 H), 7.10 (d, J = 8.4 Hz, 1 H), 7.01 (d, J = 8.6 Hz, 1 H), 
6.98-6.93 (m, 2 H), 6.83 (d, J = 8.4 Hz, 1 H), 5.08 (d, J = 11.6 Hz, 1 H), 4.49 (dd, J = 11.6, 6.7 Hz, 1 H), 
3.88 (s, 3 H), 3.87 (s, 3 H), 3.780 (s, 3 H), 3.777 (s, 3 H), 3.54 (d, J = 6.7 Hz, 1 H), 0.75 (s, 9 H), 0.13 
(s, 3 H), -0.01 (s, 3 H).  
13C NMR (100 MHz, CDCl3) δ 206.7, 170.5, 155.2, 152.2, 148.8, 148.2, 126.2, 124.7, 121.2, 119.5, 
112.9, 111.8, 111.1, 110.3, 101.5, 90.1, 72.9, 56.0, 55.9, 55.8, 53.6, 49.2, 25.4 18.2, -3.3, -3.4. 
LRMS (ESI+) m/z (%) = 567 (100, [M+Na]+, C28H36O9SiNa), 583 (95, [M+K]+, C28H36O9SiK). 
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HRMS (ESI+) calculated for C28H36O9Si23Na 567.2026; found 567.2029. 
Rf (0.23) pet/EtOAc = 1:1. 
 
1H NMR (400 MHz, CDCl3) δ 6.93-6.85 (m, 5 H), 6.80 (d, J = 2.3 Hz, 1 H), 4.77 (dd, J = 13.4, 2.5 Hz, 1 
H), 4.15 (d, J = 13.4 Hz, 1 H), 3.87 (s, 3 H), 3.85 (s, 3 H), 3.77 (s, 3 H), 3.75 (s, 3 H), 2.59 (d, J = 2.5 
Hz, 1 H), 0.85 (s, 9 H), 0.35 (s, 3 H), 0.22 (s, 3 H).  
13C NMR (100 MHz, CDCl3) δ 207.8, 167.5, 155.3, 154.1, 148.92, 148.91, 125.7, 125.4, 121.4, 118.3, 
112.3, 111.4, 111.2, 109.5, 96.1, 89.0, 73.6, 56.0, 55.9, 55.8, 53.7, 53.0, 25.8, 18.4, -2.2, -2.8.  
LRMS (ESI+) m/z (%) = 567 (100, [M+Na]+, C28H36O9SiNa), 583 (10, [M+K]+, C28H36O9SiK). 
HRMS (ESI+) calculated for C28H36O9Si23Na 567.2026, found 567.2024. 
Rf (0.35) pet/EtOAc = 1:1. 
 
1H NMR (400 MHz, CDCl3) δ 7.28 (d, J = 2.6 Hz, 1 H), 6.93 (dd, J = 8.8, 2.6 Hz, 1 H), 6.76 (d, J = 8.2 
Hz, 1 H), 6.73 (d, J = 8.8 Hz, 1 H), 6.56 (d, J = 8.2 Hz, 1 H), 6.40 (s, 1 H), 4.82 (s, 1 H), 3.90 (d, J = 11.1 
Hz, 1 H), 3.85-3.79 (m, 10 H), 3.74 (s, 3 H), 1.95 (d, J = 9.5 Hz, 1 H), 1.00 (s, 9 H), 0.88 (s, 9 H), 0.29 
(s, 3 H), 0.27 (s, 3 H), 0.11 (s, 3 H), -0.42 (s, 3 H).  
13C NMR (100 MHz, CDCl3) δ 170.1, 154.0, 153.7, 148.8, 148.6, 126.9, 124.5, 121.9, 119.2, 113.4, 
112.2, 111.1, 110.7, 100.9, 95.1, 89.9, 77.9, 57.5, 56.2, 55.8, 55.7, 53.1, 26.3, 26.1, 18.4, 18.3, -1.6, -
1.7, -2.2, -4.5. 
LRMS (ESI+) m/z (%) = 699 (100, [M+Na]+, C34H52O10Si2Na). 
HRMS (ESI+) calculated for C34H52O10Si223Na 699.2997, found 699.2991. 
Rf (0.50) pet/EtOAc = 1:1. 
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Swern Oxidation of Compounds 13, 14 and 15 and TBAF Deprotection 
In an oven dried 100 mL two neck round bottom flask, DMSO (920 mg, 11.8 mmol, 10 equiv) was 
dissolved in 20 mL of dry DCM under nitrogen at -78 °C. TFAA (743 mg, 3.54 mmol, 3.0 equiv) was 
added dropwise and the cloudy solution was stirred at -78 °C for 20 minutes at which time a solution of 
compounds 13, 14 and 15 (total 1.18 mmol, 1.0 equiv) in 6 mL of DCM was added dropwise. The orange 
mixture was stirred at the same temperature for 1.5 h at which time i-Pr2NEt (1.52 g, 11.8 mmol, 10 
equiv) was added dropwise and the reaction was stirred at -78 °C for a further one hour. Aqueous 1 M 
HCl solution was added and the flask was warmed to room temperature. The mixture was extracted with 
DCM and the organic layers were washed with brine, dried with MgSO4 and concentrated in vacuo. 
Purification was achieved with flash column chromatography using pet/EtOAc = 3:2 as the eluent, 
affording diketone (with minor quantities of the TBS hemiacetal) as a yellow solid that was subjected to 
the TBAF deprotection step immediately. 
In a 250 mL round bottom flask, diketone was dissolved in 4 mL of THF under nitrogen at room 
temperature. TBAF (1.0 M in THF, 4.72 mmol, 4.0 equiv) was added dropwise to the solution and the 
reaction was stirred at room temperature for 12 hours at which time the solvent was removed under 
reduced pressure and the residue was diluted with 25 mL of saturated NH4Cl solution and     50 mL of 
EtOAc:Et2O = 2:1 (v/v). The aqueous layer was further extracted with another 50 mL of EtOAc: Et2O = 
2:1 (v/v) and the combined organic layers were washed with brine, dried with MgSO4 and concentrated 
under reduced pressure. The crude material was purified with flash column chromatography using a 
gradient eluent of DCM:MeOH = 97.5:2.5 to 95:5 to afford diketone 16, existing exclusively as its enol 
tautomer as a yellow solid (482 mg, 1.13 mmol, 95% yield over two steps). 
1H NMR (400 MHz, (CD3)2CO) δ 9.45 (br s, 1 H), 7.76 (d, J = 2.1 Hz, 1 H), 7.65 (dd, J = 8.6, 2.1 Hz, 1 
H), 7.06 (d, J = 8.6 Hz, 1 H), 6.97 (d, J = 2.7 Hz, 1 H), 6.92 (dd, J = 8.8, 2.7 Hz, 1 H), 6.85 (d, J = 8.8 
Hz, 1 H), 5.97 (br s, 1 H), 3.88 (s, 3 H), 3.82 (s, 3 H), 3.75 (s, 3 H), 3.72 (s, 3 H). 
13C NMR (100 MHz, (CD3)2CO) δ 195.2, 169.2, 156.0, 154.0, 151.7, 150.2, 150.0, 133.8, 126.5, 125.6, 
123.6, 119.1, 113.4, 112.44, 112.43, 110.0, 96.1, 85.3, 56.3, 56.1, 56.0, 53.1. 
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LRMS (ESI+) m/z (%) = 451 (100, [M+Na]+, C22H20O9Na) 
HRMS (ESI+) calculated for C22H21O9 429.1180, found 429.1186. 
Rf (0.26) DCM/MeOH = 95:5. 
  
135
S15 
SmI2 Mediated Deoxygenation of 16 
In a 50 mL two neck round bottom flask, compound 16 (282 mg, 0.659 mmol, 1.0 equiv) and t-BuOH 
(254 mg, 3.43 mmol, 5.2 equiv) were dissolved in 15 mL of THF and the solution was degassed by 
bubbling argon through a needle at room temperature. SmI2 (1.38 mmol, 2.1 equiv) was added dropwise 
to the reaction mixture and stirred for 10 minutes at which time the flask was opened to air and 1 M HCl 
solution was added. The mixture was extracted with EtOAc and the organic layers were washed with 
brine, dried with MgSO4 and concentrated under reduced pressure. Purification was achieved using 
flash column chromatography using pet/EtOAc = 2:3 as the eluent to afford compound 17 as a pale 
yellow solid (138 mg, 0.334 mmol, 51% yield).  
Note: Enantiomerically pure samples of 17 were obtained with preparative chiral HPLC using 100% 
MeCN as the eluent. The separated enantiomers were subsequently subjected to BBr3 deprotection 
which gave enantiopure samples of suillusin (1) in order to measure the specific rotation (see S40 for 
details). These procedures were taken as separation of suillusin (1) using preparative chiral HPLC was 
difficult due to the poor resolution and insolubility of the material. 
1H NMR (400 MHz, CDCl3) δ 7.73 (d, J = 2.1 Hz, 1H), 7.67 (dd, J = 8.5, 2.1 Hz, 1H), 6.97 (d, J = 2.2 Hz, 
1H), 6.94 (d, J = 8.5 Hz, 1H), 6.83 (d, J = 8.8 Hz, 1H), 6.77 (ddd, J = 8.8, 2.7, 0.8 Hz, 1H), 6.44 (s, 1H), 
4.27 (s, 1H), 3.93 (s, 6H, coincident resonances), 3.77 (s, 3H), 3.75 (s, 3H). 
13C NMR (100 MHz, CDCl3) δ 196.0, 171.2, 155.1, 153.2, 150.6, 148.9, 148.1, 135.6, 123.9, 122.9, 
121.5, 116.1, 111.9, 111.4, 111.0, 109.6, 90.7, 56.0, 55.90, 55.88, 55.82, 53.4. 
LRMS (ESI+) m/z (%) = 435 (100 [M+Na]+, C22H20O8Na) 
HRMS (ESI+) calculated for C22H21O8 413.1231, found 413.1233. 
Rf (0.43) pet/EtOAc = 1:1. 
[α]D22.7 = -773.10 (Peak 1), +634.50 (Peak 2) (c = 1.0, MeOH)
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BBr3 Deprotection of 17 - Synthesis of (±)-Suillusin (1) 
 
In a 50 mL oven-dried round bottom flask, compound 17 (60.0 mg, 0.146 mmol, 1.0 equiv) was dissolved 
in 4 mL of dry DCM under nitrogen and the solution was cooled to -78 °C. Boron tribromide (1.0 M in 
DCM, 1.46 mmol, 10 equiv) was added dropwise and stirred at -78 °C for four hours. Subsequently, the 
flask was warmed to 0 °C and stirred for three hours at which time quench was ed with saturated NH4Cl 
solution. The reaction was extracted with EtOAc, washed with brine, dried with Na2SO4 and 
concentrated under reduced pressure. Purification was achieved using flash column chromatography 
using a gradient eluent (DCM:MeOH = 97.5:2.5 to 95:5) to afford suillusin (1) as a pale yellow solid (34.2 
mg, 0.092 mmol, 63% yield). Spectroscopic data matched the values published in the isolation paper.6 
1H NMR (400 MHz, CD3OD) δ 7.65 (d, J = 2.2 Hz, 1H), 7.44 (dd, J = 8.5, 2.2 Hz, 1 H), 6.83 (d, J = 2.3 
Hz, 1 H), 6.80 (d, J = 8.5 Hz, 1H), 6.69 (d, J = 8.6 Hz, 1 H), 6.65 (ddd, J = 8.6, 2.3, 0.8 Hz, 1 H), 4.16 
(br s, 1 H), 3.73 (s, 3 H).   
13C NMR (100 MHz, CD3OD) δ 197.8, 173.4, 153.7, 153.4, 151.0, 148.2, 146.2, 137.2, 125.3, 123.8, 
122.7, 117.3, 117.0, 116.2, 112.2, 111.7, 91.9, 56.8, 53.7. 
LRMS (ESI+) m/z (%) = 393 (100 [M+Na]+, C19H14O8Na) 
HRMS (ESI+) calculated for C19H15O8 371.0767, found 371.0768. 
Rf (0.10) DCM/MeOH = 95:5. 
[α]D22.0 = -822.20 (Peak 1) and +748.80 (Peak 2) (c = 1.0, MeOH) 
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Comparison of Synthetic (±)-Suillusin with Natural Isolate 
Table 1 - Comparison of 1H NMR data for the isolated natural product and synthetic sample 1 (in CD3OD) 
Natural sample6 δ (ppm), 600 MHz Synthetic sample (1) δ (ppm), 400 MHz 
7.64 (1 H, d, J = 2.0 Hz) 7.65 (1 H, d, J = 2.2 Hz) 
7.42 (1 H, dd, J = 8.8, 2.0 Hz) 7.44 (1 H, dd, J = 8.5, 2.2 Hz) 
6.81 (1 H, dd, J = 2.4, 1.0 Hz) 6.83 (1 H, d, J = 2.3 Hz) 
6.79 (1 H, d, J = 8.8 Hz) 6.80 (1 H, d, J = 8.5 Hz) 
6.68 (1 H, d, J = 8.8 Hz) 6.69 (1 H, d, J = 8.6 Hz) 
6.64 (1 H, ddd, J = 8.8, 2.4, 1.0 Hz) 6.65 (1 H, ddd, J = 8.6, 2.3, 0.8 Hz) 
4.15 (1 H, br s) 4.16 (1 H, br s) 
3.72 (3 H, s) 3.73 (3 H, s) 
Table 2 - Comparison of 13C NMR data for the isolated natural product and synthetic sample 1 (in CD3OD) 
Natural sample6 
δ (ppm), 150 MHz 
Synthetic sample (1) 
δ (ppm), 100 MHz 
197.8 197.8 
173.5 173.4 
153.8 153.7 
153.4 153.4 
151.0 151.0 
148.3 148.2 
146.2 146.2 
137.2 137.2 
125.3 125.3 
123.9 123.8 
122.8 122.7 
117.4 117.3 
117.1 117.0 
116.2 116.2 
112.2 112.2 
111.7 111.7 
91.9 91.9 
56.9 56.8 
53.7 53.7 
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Chiral UPC Traces 
Compound (±)-9a 
Compound (±)-9b 
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Compound 17
Racemic sample 
(‒) 
(+) 
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Crystallographic Analysis 
Structure Determinations 
The images for 9a, 9b, 15 and 17 were measured on a diffractometer (Cu Kα, mirror monochromator, λ 
= 1.54184 Å) fitted with an area detector and the data extracted using the CrysAlis package.1 The 
structures of these compounds were solved with ShelXT2 and refined using ShelXL3 in OLEX2.4 Atomic 
coordinates, bond lengths and angles, and displacement parameters have been deposited at the 
Cambridge Crystallographic Data Centre (CCDC no. 1871242, 1871243, 1871244 and 1871245). 
These data can be obtained free-of-charge via www.ccdc.cam.ac.uk/data_request/cif, by emailing 
data_request@ccdc.cam.ac.uk, or by contacting The Cambridge Crystallographic Data Centre, 12 
Union Road, Cambridge CB2 1EZ, UK; fax: +44 1223 336033. 
Crystallographic Data 
Crystallographic Data for 9a 
C22H22O8, M = 414.39, T = 150 K, orthorhombic, space group Pbca, Z = 8, a = 10.70455(4), b = 
17.64394(8), c = 20.57722(9) Å, V = 3886.43(3) Å3, Dx = 1.416 g cm-3, 3931 unique data (2σmax = 148.0°), 
R = 0.040 [for 3767 reflections with I > 2.0σ(I)]; Rw = 0.110 (all data), S = 1.02. 
Crystallographic Data for 9b 
C22H22O8, M = 414.39, T = 150 K, triclinic, space group P-1 (No. 2), Z = 4, a = 8.1180(2), b = 11.7561(2), 
c = 20.6987(5) Å, α = 92.172(2), β = 95.586(2), γ = 97.782(2)°, V = 1945.30(8) Å3, Dx = 1.415 g cm-3, 
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7854 unique data (2σmax = 147.8°), R = 0.052 [for 7075 reflections with I > 2.0σ(I)]; Rw = 0.147 (all data), 
S = 1.02. 
Crystallographic Data for 15 
C34H52O10Si, M = 676.93, T = 150 K, monoclinic, space group I2/a, Z = 8, a = 21.6944(2), b = 10.9452(1), 
c = 32.2956(2) Å, β = 103.943(1)°, V = 7442.63(11) Å3, Dx = 1.208 g cm-3, 7463 unique data (2σmax = 
147.8°), R = 0.047 [for 6996 reflections with I > 2.0σ(I)]; Rw = 0.134 (all data), S = 1.03. 
Crystallographic Data for 17 
C22H20O8, M = 412.38, T = 150 K, monoclinic, space group P21/c, Z = 4, a = 7.8422(2), b = 13.4840(3), 
c = 19.1741(4) Å, β = 97.458(2)°, V = 2010.40(8) Å3, Dx = 1.362 g cm-3, 4031 unique data (2σmax = 
147.4°), R = 0.042 [for 3704 reflections with I > 2.0σ(I)]; Rw = 0.120 (all data), S = 1.04. 
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Conclusions and Future Work 
The manuscripts presented in this thesis portray a body of research that was devoted to 
methodology development and applications for efficient syntheses of polyoxygenated 
heterocycles. In particular, our efforts centered on formulating innovative solutions to 
address synthetic challenges by means of reaction development and effective application of 
existing methodologies to prepare compounds of practical importance. The intertwining of 
reaction discovery and strategy development ultimately enabled the first syntheses of suillusin 
(28) (10 steps) and dibenzofurans isolated from Ribes takare (three and five steps) in addition 
to the shortest synthesis reported to date of boletopsin 11 (1) (nine steps).  
Chapter Two summarizes the evolution of a synthetic method that exploited the innate 
reactivity of o-benzoquinone in the synthesis of polyoxygenated dibenzo[b,d]furan 
frameworks with minimal extraneous protecting group manipulations. We developed a 
unique approach that leveraged simple phenols and o-benzoquinones to assemble the 
dibenzofuran framework 58 through a Michael-oxidation-oxa-Michael addition sequence 
(Scheme 19). The versatility of this strategy was probed with a broad variety of phenolic 
coupling partners, and the utility of the method was demonstrated with a succinct total 
synthesis of two dibenzofuran natural products.  
Scheme 19. Constructing Polyoxygenated Dibenzofurans through a Michael-oxidation-oxa-Michael 
Cascade and Application in Natural Product Synthesis 
  
The methodology presented herein utilized mild and robust reaction conditions and should 
be amenable to a wider substrate scope. For example, varying the o-benzoquinone 
substitution pattern or replacing the nucleophile with aniline or thiophenol derivatives could 
lead to polyoxygenated carbazoles and dibenzothiophene analogues (Scheme 20A). The 
efficient, albeit unexpected formation of the dearomatized cyclohexa-2,5-dien-1-ones could 
be investigated in future methodological studies to fashion complex molecular scaffolds 
(Scheme 20B). 
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Scheme 20. Proposed Substrate Scope and Future Studies of the Cyclohexa-2,5-dien-1-one Scaffold 
 
The chemistry described in Chapter Three combines the foundation for dibenzofuran 
synthesis discussed in Chapter Two with Yu and co-workers’ pioneering work on transient 
directing group-enabled C-H activation to achieve a streamlined synthesis of boletopsin 11 
(1). The crux of the synthesis involved a one-step oxidation-oxa-Michael sequence to furnish 
the dibenzofuran core followed by a Pd-catalyzed transient directed ortho-C(sp2)-H arylation 
reaction to assemble the entire molecular framework (Scheme 21A).  
Scheme 21. The Nine-Step Synthesis of Boletopsin 11 (1) and the Discovery of a Tandem C(sp2)-H 
Arylation Reaction 
 
Not only does this approach represent the first application of Yu’s methodology in total 
synthesis, but it also led to the discovery of an unprecedented tandem directed C(sp2)-H 
arylation event (Scheme 21B). Future investigations will focus on rendering this 
transformation enantioselective with enantiopure transient directing groups to deliver axially 
chiral triaryls (Scheme 22).55  
167 
 
 
 
Scheme 22. Proposed Strategy to Access Chiral Triaryls Using the Tandem Directed C(sp2)-H 
Arylation Reaction 
 
Our investigations in the synthesis of polyoxygenated heterocycles concluded in Chapter 
Four with the disclosure the first total synthesis of suillusin (28) (Scheme 23). Key to the 
success of the route was a one-pot Michael-benzoin multicatalytic cascade that installed the 
entirety of the skeletal carbons and a Rubottom-Swern oxidation sequence to furnish the 
desired oxidation state of the cyclopentenone core.  
Scheme 23. First Total Synthesis of Suillusin (28) and Confirmation of Absolute Stereochemistry 
  
The successful synthesis of suillusin allowed for the comparison of the enantiopure specific 
rotation ([α]D22.0 = -822, c 1.0, MeOH) with the values published in the original isolation 
paper ([α]D = 4, c 1.0, MeOH). The racemic nature of the original sample was confirmed 
upon comparison of the specific rotation of the natural isolate and the synthetic sample. 
Furthermore, the absolute stereochemistry of (-)-(3aR,8bS)-suillusin was unequivocally 
determined through X-ray crystallography (see Appendix page 172 for details).56,57 
Successful chiral HPLC separation of the racemic material enabled us to validate the 
hypothesis discussed in Chapter One that the biosynthesis of suillusin involves a 
spontaneous oxidative rearrangement. 
Overall, the work presented in this thesis details our pursuits in constructing polyoxygenated 
heterocyclic frameworks through the synergy of method development and natural product 
synthesis. With viable synthetic routes in hand, we have now set the stage to probe the 
biological activity and the biosynthetic origin of these unique fungal natural products. The 
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research described in this thesis therefore demonstrates the importance of crafting new 
synthetic methodology as an enabling tool for total synthesis, and also showcases how 
judicious synthetic planning can be the key to simplifying a problem.  
From a fundamental standpoint, studies in total synthesis encourage novel bond 
disconnections that help identify uncharted areas of chemical reactivity and lead to new 
reaction development. Those strategies and concepts can be tested in the construction of 
complex natural products—a proving ground for new synthetic methodologies. Total 
synthesis can also be applied effectively to obtain sufficient quantities of material necessary 
for ensuing investigations, whether that is structure determination of natural products or 
evaluation of bioactivity. A modular synthetic route can allow access to a diverse library of 
structural analogues to pursue exhaustive high-throughput screening. Oftentimes, 
serendipitous discoveries that are identified during these synthetic undertakings can foster 
new ideas that ultimately push the boundaries of this ever-expanding field. Above all, the 
entire enterprise is an excellent platform for training chemists to be persistent, adventurous 
and creative.  
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Appendix 
X-ray Structure Report of (-)-(3aR,8bS)-Suillusin 
Structure Determination 
The image for (-)-(3aR,8bS)-suillusin was measured on a diffractometer (Cu Kα, mirror 
monochromator, λ = 1.54184 Å) fitted with an area detector and the data extracted using the 
CrysAlis package.1 The structure of this compound was solved with ShelXT2 and refined 
using ShelXL3 in OLEX2.4 Atomic coordinates, bond lengths and angles, and displacement 
parameters have been deposited at the Cambridge Crystallographic Data Centre (CCDC no. 
1873655). 
Crystallographic Data for (-)-(3aR,8bS)-suillusin 
 
C19H14O8, M = 370.30, T = 150 K, orthorhombic, space group P212121, Z = 4, a = 7.4131(2), 
b = 14.2088(3), c = 15.2437(4) Å, V = 1605.64(7) Å3, Dx = 1.532 g cm
-3, 3218 unique data 
(2σmax = 149.2°), R = 0.040 [for 3046 reflections with I > 2.0σ(I)]; Rw = 0.113 (all data), S = 
1.07. 
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